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Prolonged exposure to fatty acids (FAs), at levels normally seen during fasting, can be 
cytotoxic in vulnerable cells including preadipocytes. Prior work from our laboratory has shown 
that FAs cause mitochondrial inner membrane (MIM) permeabilization due to the formation of 
the permeability transition pore (PTP) and ultimately cell death. Cyclophilin D (CypD) is well 
known, and the F1F0 ATP synthase has emerged, to be necessary for PTP. However, the role of 
the Bcl-2 (b-cell lymphoma 2) family members in the formation of the PTP is less clear. The 
 
 
initial hypothesis was that the cytotoxicity of FAs in primary human preadipocytes correlates 
with the binding of CypD to, and the release of Bcl-xL (b-cell lymphoma extra-large) from, the 
F1F0 ATP synthase complex. 
Our results showed a wide range of FA sensitivity in primary human preadipocytes as the 
number of cells undergoing MIM permeabilization and cell death was 2.3-fold and 3.4-fold 
higher, respectively, in groups labeled FA-sensitive (FAS) compared to the groups labeled FA-
resistant (FAR) quintile. The purpose of selecting these groups was to examine differences in 
mitochondrial handling of elevated FAs and how this led to differences in preadipocyte cell 
death. Under thought of the adipose expandability hypothesis, we hypothesize that decreased 
preadipocyte number (indicative of our FAS group) during times of elevated FAs could play a 
role in adipose tissue dysfunction and the resulting metabolic abnormalities known as the 
metabolic syndrome. Furthermore, MIM permeabilization and cell death were prevented by 
incubating preadipocytes with mitochondrion-selective superoxide and lipid peroxide targeting 
antioxidants MitoTempo and MitoQ, as well as L-carnitine. 
Co-immunoprecipitation showed CypD was already present in the F0F1 ATP synthase 
complex and not further incorporated following FA exposure. Cyclosporine A (CsA), which 
induced the dissociation of CypD from the F0F1 ATP synthase, prevented FA-induced 
cytotoxicity. We confirmed that Bcl-xL binds to the F0F1 ATP synthase and that FAs induced the 
release of Bcl-xL. ABT-737, which inhibits Bcl-xL protein to protein interactions, exacerbated 
FA-induced ATP depletion and eliminated mitochondrial respiratory reserve capacity in the FAR 
preadipocytes only. However, this only marginally affected cell viability. Interestingly, FA 
exposure induced the expression of the carnitine acetyltransferase and sirtuin 3 (SIRT3) genes in 
 
 
the FAR preadipocytes only. We propose that SIRT3 induction decreased acetylation of the F1Fo 
ATP synthase.  
Altogether the results of our first study illustrated that FAs cause a CypD-mediated MIM 
permeabilization that is responsible for cell death. FAs also lead to ATP depletion, but it is not 
the cause of cell death. Additionally, FAs increase F1Fo ATP synthase acetylation, but it does not 
explain the full extent of cell death or FA sensitivity. 
In our second study we furthered the aforementioned work by hypothesizing that 
improving preadipocytes FA sensitivity will correlate with improvements in metabolic health 
following 12 weeks of exercise training. As observed in our older cohort, the FA sensitivity of 
preadipocytes ranged several folds. Interestingly, FA sensitivity correlated with lower high-
density lipoprotein-cholesterol (HDL-c) levels. Following the training program, the individuals 
that improved their FA sensitivity also decreased their low-density lipoprotein-cholesterol (LDL-
c) levels. One goal of the exercise study was to assess whether fatty acid sensitivity testing prior 
to exercise could predict the effectiveness of exercise on metabolic health. Though no 
significance was found, there was a trend for pre-exercise fatty acid sensitivity to correlate with 
the changes in triglycerides and HDL-c after exercise.  
The work done in this dissertation provides a deeper understanding of how chronically 
elevated levels of FA can cause mitochondrial dysfunction and preadipocyte death. The variance 
in this sensitivity to the toxic effects of FA need further elucidation yet could possibly be at play 
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CHAPTER 1 INTRODUCTION 
Obesity and the Metabolic Syndrome 
The CDC estimates that over one-third of the U.S adult population (116 million) have 
obesity, which is defined as a grossly overweight state of BMI>30. Though obesity may not be 
considered by some to be a disease on its own, it is among a group of conditions known as the 
metabolic syndrome that are highly associated with diabetes, cardiovascular disease (CVD), and 
other diseases [1] [2] [3]. Other risk factors include hyperglycemia; high blood pressure; high 
cholesterol and triglyceride (TG) levels; elevated low-density lipoprotein-cholesterol (LDL-c); 
and decreased high density lipoprotein cholesterol (HDL-c) levels; and insulin resistance. 
Furthermore, the risk of having these risk factors is closely linked to obesity and the lack of 
physical activity. Metabolic syndrome is becoming more common with the rise in obesity rates 
and may overtake smoking as the leading risk factor for heart disease. Due to the close 
relationship of obesity, diabetes, and cardiovascular disease, and the alarming mortality rates 
associated with these diseases, determining the mechanisms at the origin of obesity are key in 
prevention of these diseases in the future. 
 
Adipose Tissue 
Adipose tissue is the primary organ of which energy, in the form of fat, is stored. 
Adipocytes make up the primary cell type in adipose tissue and are responsible for storing 
energy in times of excess and releasing energy in times of need. This ability to store fat without 
lipotoxicity that is exhibited in mostly every other organ makes adipose tissue highly unique and 
a vital aspect in whole body metabolism. Aside from fat storage, adipose tissue has other 
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functions including acting as a secretory organ, secreting hormones, proteins, and other factors 
that contribute to energy homeostasis, inflammation, angiogenesis, as well as immunity [4]. 
Other cell types in adipose tissue include adipocyte precursor cells, preadipocytes, fibroblasts, 
vascular endothelial cells, and a variety of immune cells. However, multitudes of evidence show 
that the normal functions of adipose tissue can become compromised with obesity, and this loss 
of function, aka adipocyte dysfunction, is the basis for much of pathophysiology corresponding 
with the metabolic syndrome [4].  
 
Mechanisms of Obesity 
Mechanisms of the onset of obesity are not fully known, but it is believed to be a result of 
a chronic positive energy imbalance, being more energy consumed than physiologically needed.  
Upon an increase in energy, adipose tissue must respond by increasing fat storage. Adipose 
tissue can increase fat storage by increasing fatty acid (FA) uptake from the serum, and 
esterifying FA to store them as TG in lipid droplets within the adipocyte. Chronically however, 
this increase in fat storage is primarily achieved by either increasing adipocyte size 
(hypertrophy), or adipocyte number (hyperplasia). Adipocyte hyperplasia occurs at early stages 
in adipose tissue development, whereas hypertrophy occurs prior to hyperplasia to meet 
increased fat storage needs [5] [6]. However adipose tissue seems to have a limit to its 
hypertrophic and hyperplastic abilities.  
In obesity, hypertrophic adipocytes reach a point that the excess fat storage is detrimental 
to the adipose tissue as a whole, leading to adipocyte dysfunction. During this phase, the 
adipocytes grow at a rate that exceeds angiogenesis rates, or the creation of new blood vessels to 
supply oxygen and nutrients to the cells. With a lack of oxygen and nutrients, these cells can 
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become hypoxic, leading to the activation of hypoxia-inducible factor 1α, a transcription factor 
that serves as an oxygen sensor in the cell [7]. Hypoxia is a condition that is toxic to cells and 
leads to a pro-inflammatory response, which may impair insulin sensitivity [8]. This pro-
inflammatory state of adipose tissue during excess energy imbalance is a hallmark of adipose 
tissue dysfunction and obesity, and is characterized by an increase in pro-inflammatory cytokine 
release and macrophage infiltration. Furthermore, adipose tissue dysfunction leads to excess FA 
release systemically to other organs such as the liver, pancreas, skeletal muscle, and the heart, 
which are not equipped to handle elevated FA loads. Indeed, recent evidence suggests that once 
adipocyte functional capacity has been exceeded, metabolic diseases occur [9] [10]. 
Interestingly, decreasing this elevated FA load in the serum improves insulin sensitivity in obese 
and T2D individuals [11] [12]. 
Evidence suggests that adipocytes may become dysfunctional due to an inability to 
increase fat mass, and this highly correlates, and possibly precedes, development of the 
metabolic syndrome. This phenomenon has given rise to the adipose tissue expandability 
hypothesis, which puts this dysfunction of adipogenic turnover as a key factor in linking energy 
imbalance and the metabolic syndrome, rather than obesity [13]. The hypothesis states that once 
adipose tissue loses its ability to store fat, then net lipid flux to non-adipose tissues increases and 
lipids begin to be deposited ectopically. This ectopic deposition in organs not meant to store 
lipids leads to insulin resistance and apoptosis, and further progression to the metabolic 
syndrome [10] [13] [14]. This dissertation is in agreement with the adipose tissue expandability 
hypothesis, and experiments within sought to answer questions as to how fat becomes lipotoxic 




Metabolically Healthy Obese vs. Unhealthy Obesity 
If there was a simple correlation between insulin resistance and adipose tissue mass, then 
all individuals with similar amounts of adipose tissue would be diabetic, which is not true. 
Despite the significant correlations between obesity and metabolic diseases, there exists a 
subpopulation of obese individuals that do not display metabolic abnormalities, “metabolically 
healthy obese” individuals (MHO) [15]. This subset of the obese population is still unclear but is 
estimated to occur in about 15% of the total obese population. As mentioned before, 
metabolically unhealthy obese (MUO) individuals have a reduced number of adipocytes that are 
larger in size and exist in a chronic pro-inflammatory state including a M1 polarized macrophage 
phenotype [15] [16] [17]. On the other hand, MHO individuals display a greater number of 
adipocytes that are smaller in size, and display an anti-inflammatory profile, with more M2 
polarized macrophages [15] [18] [19]. Additionally, these MHO individuals have a greater 
adipogenic potential, which is the ability of adipose tissue to differentiate adipocyte precursor 
cells, preadipocytes, into mature adult adipocytes. This phenomenon is in support of the adipose 
tissue expandability hypothesis and provides rationale to further investigate obesity-induced 
changes within the adipogenic environment. Further elucidating the mechanisms that determine 
MHO vs. MUO may provide an effective target in treating obesity or preventing the progression 
towards metabolic diseases. 
 
Preadipocytes Roles in Disease 
It used to be common thought that adipose tissue is resistant to the toxic effects of FAs, 
however recent literature suggests that adipose tissue is one of the first tissues to experience 
lipotoxicity in obese models [20] [21]. In order for adipose tissue to maintain its storage function 
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and capacity, hypertrophic adipocytes during a chronic energy imbalance phase must be replaced 
by new, healthy adipocytes. This is achieved by the differentiation of preadipocytes into smaller, 
healthy adipocytes. However with adipose dysfunction in the obese state, preadipocyte turnover 
has been found to be decreased, halting the ability of adipose tissue to perform their FA storage 
function [21] [14] [22]. How this decrease in turnover comes about is still not known.  
Preadipocyte differentiation is under control of a host of transcription factors such as 
ccaat-enhancer-binding proteins and peroxisome proliferator-activated receptor γ (PPARγ). 
Studies have suggested that in the obese state, PPARγ expression is reduced, as well as 
preadipocyte number, which may be the result of increased FA exposure [14] [23]. PPARγ 
deficiency is also correlated with severe insulin resistance, shown by multiple genetic and rodent 
models [24], 
As mentioned before, with chronic positive energy imbalance and the development of 
adipocyte dysfunction, there’s a resulting excess pool of FAs. FAs are normally bound by two 
fates in adipose tissue; 1) esterification and storage; or 2) used by the mitochondria for energy 
production via β-oxidation. Preadipocytes have a low FA esterification rate, causing a reductive 
pressure upon nutrient overload. This pressure to handle the increased FA load is represented as 
an increase in NADH and FADH2 greater than the levels needed to regenerate ATP [25] [26]. As 
a result, mitochondrial ROS production is increased, and chronically elevated ROS levels may 
lead to mitochondrial dysfunction, a hallmark of obesity. Previous work done in immortalized 
preadipocytes by Rogers et al, has shown that upon FA exposure, representative of nutrient 
overload, a sequence of events occurs within the mitochondria which leads to it becoming 
dysfunctional [27]. Initially FA cause an increase in ROS formation. This ROS may “prime” the 
preadipocytes for a sequence of events later on that ultimately leads to a cellular energetic crisis 
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and cell death. Among these events are nicotinamide adenine dinucleotide (NAD+) depletion, 
increase in mitochondrial inner membrane (MIM) permeability, and ATP depletion [27]. Rogers 
also found for this FA-toxicity to be dependent on formation of the permeability transition pore 
(PTP). Work in this dissertation investigated the sequence of these events leading to FA-induced 
preadipocyte death, as well as the mechanism and structure of permeability transition pore (PTP) 
in preadipocytes.  
 
Mitochondrial Permeability Transition Pore 
Dysfunctional mitochondria are at the center of the pathophysiology for a number of 
diseases including; neurodegenerative diseases such as Alzheimer’s, Huntington’s, and 
Parkinson’s disease; multiple sclerosis; Friederich’s ataxia; fibromyalgia; autistic spectrum 
disorder; cancer; as well as CVD and diabetes. Though exact mechanisms vary, mitochondrial 
dysfunction is characterized by a loss in the maintenance of the electrochemical gradient of the 
MIM needed for ATP regeneration; alterations of the functions of the electron transport chain 
(ETC); or a decrease in the transport of vital metabolites into the mitochondria. Among the 
possible pitfalls that may cause mitochondrial dysfunction, the PTP is believed to be at the center 
of a number of the aforementioned diseases [28] [29] [30]. PTP is described as a large 
conductance pore that causes the collapse of the chemiosmotic gradient across the MIM, 
effectively halting ATP regeneration, and through prolonged opening, promoting cell death. 
Though its role in disease has been extensively studied in the past decade, the components that 
make up the PTP are still up for debate. 
PTP was first discovered in 1975 by Haworth and Hunter, who found for Ca2+ addition to 
cause an increase in mitochondrial permeability, an uncoupling from oxidative phosphorylation, 
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and mitochondrial swelling [31]. Since then it has been found for PTP to be modulated by a 
number of different factors; pore opening is increased by Ca2+  addition,  inorganic phosphate 
(Pi), reactive oxygen species generation (ROS), and mitochondrial depolarization; and pore 
opening is decreased by divalent cations such as Mg2+, increase in ΔΨ, and alterations of pH 
above/below 7.3 [31] [32]. However, modulation of PTP seems to be clearer than its actual 
composition. 
Initial studies suggested for the PTP to be a multi-component pore spanning the MIM and 
mitochondrial outer membrane (MOM); and involving adenine nucleotide translocase (ANT), 
and the voltage-dependent anion channel (VDAC) [33] [34] [35] [36]. However genetic studies 
were able to disprove both of these potential PTP components, as pore opening still occurred 
despite their genetic deletion or knockdown [37] [38]. Recently the consensus appears to include 
the F1F0 ATP synthase as being a central component of PTP, despite its characterization and 
suggestion to compose the core back in 1975 [31]. The F1F0 ATP synthase, otherwise known as 
Complex V of the ETC, is the enzyme responsible for creating energy in the cell in the form of 
ATP. Overall, the enzyme utilizes ADP, Pi, and H
+, to create ATP and H2O, which is achieved 
by utilizing the electrochemical gradient created by the ETC. 
The F1F0 ATP synthase is a large multi-component complex embedded in the MIM. It 
consists of two main subunits, F0 and F1, along with oligomycin sensitivity conferring protein 
(OSCP), which are connected by a central stalk and work together in a rotational engine 
mechanism to regenerate ATP. The F1F0 ATP synthase is commonly isolated as a functional 
monomer; however, electron microscopy studies have revealed that it exists physiologically as 
dimers, forming long rows of oligomers [39]. The F0 portion forms a transmembrane ring 
composed of a, b, and c subunits, and pumps protons back into the mitochondrial matrix. Proton 
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binding causes a rotation in the F0 subunit, which is coupled to F1 rotation by the γ stalk. The F1 
portion is composed of alpha, beta, gamma, delta, and epsilon subunits which undergo 
conformational changes (closed, open states) to bind ADP and Pi, leading to ATP regeneration 
and release. This rotational “coupling” between the subunits is vital for proper mitochondrial 
functioning and ATP regeneration and is disrupted by elevated Ca2+ levels and ROS, leading to 
PTP formation. 
 
Cyclophilin D role in PTP 
One of the only universally accepted components of the PTP is cyclophilin D (CypD).  
Consensus includes CypD as being a major component of PTP as numerous genetic and 
functional studies have detailed its role [40] [41] [42] [43].  CypD is a mitochondrial matrix 
protein and a member of the peptidylprolyl isomerase (PPIase) class of enzymes that regulate 
PTP and cell death [40]. It has been shown to bind to the lateral stalk, as well as OSCP of the 
F1F0ATP synthase regulating F1F0 ATP synthase activity, causing Ca
2+ sensitization, decreased 
ATP synthesis, and PTP formation [41] [44] [45]. Cellular stressors, such as oxidative stress, 
cause CypD translocation from the mitochondrial matrix to the MIM, allowing it to bind to the 
F1F0 ATP synthase [46] [47]. 
Genetic studies have focused on the role of CypD in PTP and disease. Stemming from 
these studies is the founding of cyclosporine A (CsA), a potent immunosuppressive agent, as 
being a CypD inhibitor and effectively inhibiting PTP [43]. Used acutely, CsA was found to be 
therapeutically beneficial in cases of I/R (ischemia/reperfusion) injury, and myocardial infarction 
[48]. In the context of obesity, CypD -/- mice exhibit an increase of white adipose tissue and 
develop early onset obesity [49]. Though CsA use as an immunosuppressive agent may limit its 
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long term use in cases of obesity and the metabolic syndrome, promising new inhibitors of CypD 
are being developed in hopes of bypassing these additional effects of CsA [50] [51]. 
Consequences of PTP opening vary on the amount of time in the open state, as well as the 
number of these “pores” in the mitochondrial population at one given time. Normal PTP opening 
is observed physiologically and is described to occur in a transient manner and play a role in 
cellular health by regulating ionic homeostasis, as well as small solute exchange between the 
cytosol and mitochondria [30] [52]. However, if this opening persists, then a sequence of events 
can occur ultimately leading to cell death. Prolonged PTP opening leads to an increase in ionic 
and small solute flux into the mitochondria, ultimately causing mitochondrial swelling [53]. This 
increase in ionic flux also dissipates the proton gradient necessary for ATP regeneration, causing 
a collapse in ΔΨ of the MIM, decreased ATP regeneration, and increase in ROS production. 
Furthermore, mitochondrial swelling can rupture the outer mitochondrial membrane causing 
cytochrome C release from the mitochondria, which is a vital component of the ETC, and 
subsequent apoptotic pathway activation [54] [55].  
 
B-cell Lymphoma Extra-Large (Bcl-xL) 
Another possible component, or at the least, modulator of PTP has been suggested to be 
B-cell lymphoma extra-large (Bcl-xL). Bcl-xL is a transmembrane mitochondrial molecule that is 
among the Bcl-2-related family of anti-apoptotic proteins. Bcl-xL is long known for its anti-
apoptotic effects thought to be due to MOM action on inhibiting the pro-apoptotic Bak/Bax [56] 
[57]. Upon apoptotic stimuli, Bax translocates to the mitochondria and promotes Cytochrome C 
release, caspase activation, and apoptosis induction [57]. Bcl-xL has been thought to inhibit Bax-
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mediated apoptosis through direct binding and prevention of Bax translocation to the 
mitochondria. 
Besides Bax inhibitory actions, Bcl-xL more recently has been suggested to modulate 
energy homeostasis. These actions include stabilizing MIM potential, and increasing metabolic 
efficiency, again conferring cellular protection [58] [59]. Recent evidence suggests these 
metabolic and protective actions may be due to Bcl-xL binding to the β-subunit of the F1F0 ATP 
synthase [59] [60]. However, the interaction between Bcl-xL and positive chronic energy 
imbalance, obesity, and adipocyte dysfunction have not been studied. Furthermore, most studies 
to date on PTP structure and composition have focused on remodeling/reconstituting model 
mitochondrial membranes, and few have studied the structure in vitro or in human models. 
 
Mitochondrial Acetyl-Coenzyme A Levels and Protein Acetylation 
As mentioned previously, post-translational modifications such as acetylation play an 
important role in oxidative stress balance, as well as bioenergetics, mitochondrial health, and 
cellular survival. Protein acetylation, a reversible modification, is affected by changes in nutrient 
availability and cellular energy status. Acetylation in the mitochondria can occur non-
enzymatically in conditions of high acetyl-coenzyme A levels [61], which is a molecule that 
participates in many biochemical reactions including protein, carbohydrate, and lipid 
metabolism. Being at the center of nutrient metabolism, acetylation thus is sensitive to metabolic 
changes. Acetylation is increased during times of fasting, and paradoxically, during times of high 
fat diet HFD [62].  
FAs enter the mitochondria through the L-carnitine shuttle (Figure 2). L-carnitine is an 
essential nutrient that serves as a substrate for a family of acetyltransferases, allowing for 
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membrane permeable transferring of fatty acyl-CoAs (FA-CoA). The shuttle consists of three 
enzymes, carnitine palmitoyltransferase 1 (CPT1), carnitine palmitoyltransferase 2 (CPT2), 
carnitine 0-acetyltransferase (CRAT), as well as the small soluble molecule central to the shuttle, 
L-carnitine. Before FAs can be transported into the mitochondria they are esterified with CoA to 
form FA-CoA. This molecule is then transported into the mitochondria via CPT1, exchanging L-
carnitine for the attached CoA, and into the matrix via CPT2 which exchanges CoA for L-
carnitine to produce FA-CoA once again, which is then ready to enter the β-oxidation process, 
with the free L-carnitine ready to transfer out to the cytosol and resupply the cytoplasmic pool of 
L-carnitine for further shuttling. Furthermore, β-oxidation results in acetyl CoA resupply within 
the mitochondria which can be utilized in the tricarboxylic acid (TCA) cycle for energy 
production, or cause acetylation of proteins. Additionally, acetyl-CoA can also be transported 





Figure 1.1. Fatty acid and acetyl CoA transport into the mitochondria via L-carnitine 
shuttle. FAs must be transported into the mitochondria via CPT1/2 for energy production. 
During β-oxidation, acetyl CoAs are generated which can further lead to energy production via 
the TCA cycle, cause non-enzymatic protein acetylation, or can be transported back out into the 




Evidence suggests perturbations in FA and acetyl CoA shuttling in/out of the 
mitochondria have an impact on mitochondrial, cellular, and organ health. CRAT, which 
converts acetyl CoA to the membrane permeant acetylcarnitine, has been shown to be a key 
regulator of substrate switching and glucose tolerance. In obesity-associated FA accumulation, 
there is a decrease in free L-carnitine and CRAT activity which lead to incomplete β-oxidation, 
and supplementing human subjects with L-carnitine enhances acetyl-carnitine urinary excretion, 
whole body glucose tolerance, and metabolic flexibility [63] [64]. Furthermore, CPT1 and 
CRAT expression has also been found to be decreased in adipose tissue in humans with obesity 
and T2D which correlated with lipid accumulation and decreased preadipocyte differentiation 
[65] [66]. However there exists a system to balance acetylation status of the mitochondria. 
 The acetylation status of proteins is regulated by NAD+-dependent protein deacetylators 
called sirtuins. There are 7 isoforms of SIRTs, however SIRT1 (cytosolic/nuclear) and SIRT3 
(mitochondrial) seem to be the most important cellular deacetylators. SIRT activity is dependent 
on NAD+ levels, suggesting their activity is directly linked to the energy status of the cell, either 
via NAD+/NADH ratio, or absolute levels of NAD+, NADH, or the intermediate, NAM 
(nicotinamide) [67]. Preliminary data in our lab have shown for 1000µM FA to cause a decrease 
in NAD+ levels, correlating with PTP and cell death. (Figure 1.2) 
Interestingly, studies have found that HFD causes decreased SIRT3 expression and 
activity, leading to mitochondrial hyperacetylation and obesity [62]. Studies utilizing SIRT3 KO 
mice demonstrate in parallel to increased mitochondrial acetylation, glucose intolerance and 
increased insulin resistance (IR) [62]. Furthermore, SIRT3 activity has also been shown to play a 
role in energy metabolism due its deacetylating actions on several mitochondrial proteins 
involved in energy pathways [68]. Since HFD/obesity both modulate acetylation and sirtuin 
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expression and activity, manipulating this relationship may provide an attractive therapeutic 








































Figure 1.2. Fatty acids cause a decrease in NAD+ levels. Immortalized preadipocytes were 
treated with 1000µM FA and NAD+ levels were assessed after 24 hours. NMN co-treatment with 
1000µM FA replenishes NAD+ pool.
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Mitochondrial Oxidative Stress 
One of the hallmarks of obesity is increased oxidative stress in adipose tissue, which is an 
early instigator of the metabolic syndrome [69]. Oxidative stress impairs glucose uptake in 
adipose tissue and decreases insulin secretion from the pancreas [70] [71]. Furthermore, HFD 
and hyperglycemia increase ROS production in adipose in obese individuals [69]. At a cellular 
level, ROS reduces oxygen consumption in adipocytes, and blocks FA oxidation, exacerbating 
already increased circulating FA levels [72]. The importance of ROS in obesity and the 
metabolic syndrome is highlighted by the finding that IR is attenuated through the use of 
selective mitochondrial antioxidants [73].  
The mitochondria is one of the main sources of cellular ROS production. There exists a 
delicate balance between ROS production and antioxidant systems within the mitochondria, but 
high concentrations of ROS may cause lipid peroxidation, carbonylation of proteins, formation 
of the PTP, and mitochondrial DNA (mtDNA) oxidative damage [74]. During oxidative 
phosphorylation, electrons are transferred down the ETC to oxygen, the final electron acceptor. 
As mentioned before, it is this passing of electrons down the ETC that creates the proton gradient 
necessary for ATP regeneration. ROS is generated at several different sites along the ETC, but 
the main sites seem to be Complex I and III, where electron passing may leak to oxygen (O2) to 
form a superoxide anion (O2-), which is the initial form of ROS in the mitochondria [74] 
(Schematic image in Figure 1). Superoxide is relatively unreactive due to its negative charge and 
poor permeability; however, it can rapidly react with nitric oxide (NO) to form the highly 
reactive oxidant peroxynitrite (ONOO-). Most superoxide is converted to hydrogen peroxide 
(H2O2) through dismutation reactions via superoxide dismutase (SOD), Hydrogen peroxide is a 
stable, membrane permeable free radical that plays a role in several different cellular processes 
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including acting as an oxidant or a signaling molecule. In fact, H2O2 is described as playing a 
vital role in cellular processes and health [75] [76] [77]. Hydrogen peroxide can be neutralized 
and converted into water (H2O) by several different antioxidants including catalase, glutathione 
peroxidase (GPx), and thioredoxin reductase (TPx). If not detoxified, it can further produce the 
highly reactive hydroxyl radical. Hydroxyl radicals are powerful oxidants that can 
indiscriminately damage several types of macromolecules including lipids causing lipid 
peroxidation. 
 As mentioned before, the mitochondria contain a well-balanced antioxidant defense 
system in order to control ROS production (Figure 1.3). Antioxidant enzymes include SOD, 
catalase, GPx, and TPx. The thioredoxin system is a vital for the protection against peroxides. 
The system is composed of TPx, thioredoxin, and thioredoxin reductase, which keeps 
thioredoxin reduced in order to act as an electron donor for TPx neutralization of H2O2. HFD has 
been shown to reduce TPx and play a role in IR [78]. 
SOD2 is a highly abundant mitochondrial antioxidant that catalyzes the dismutation of 
superoxide into oxygen and hydrogen peroxide. Previous studies have shown differential effects 
of FAs on SOD2 levels and activity, as well as its expression/activity in T2D and obesity. In one 
of those studies, FA induced oxidative stress leading to SOD2 induction, which is suggested to 
protect against the toxic effects of FAs [79]. However, FAs, which are elevated in T2D, also 
increased lipid peroxidation, which was shown to lower SOD2 activity and protein levels, and 
ultimately lead to a pro-oxidant state [79] [80].  
Another key component of mitochondrial antioxidant defense is the glutathione system, 
which essentially converts hydrogen peroxide into water. The system includes GPx, glutathione 
(GSH), which acts as the electron donor, and glutathione reductase (GSR) which reduces 
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oxidized GSH to be used again. Numerous studies have shown for greater levels of GPX4 to be 
cytoprotective in cases of elevated FA, as well as in obesity and IR [81] [82], however some 
studies include both GPX1 and GPX4, or total GPX measurements which does not discern 
between the different isozymes. This is important because there has been an opposite trend for 
reduced GPX1 activity and expression to be cytoprotective as well as insulin sensitizing [76] 
[83] [84]. GPX4 is composed of hydrophobic amino acids, allowing it to exist and interact with 
complex lipids in membrane, and is believed to be the primary defense against lipid peroxidation 
[85] [86], which may contribute to its FA buffering benefits. The study by Katunga et al, showed 
for GPX4 haploinsufficiency to cause increased lipid peroxidation in mice on a high fat/high 
sucrose diet, and for patients with diabetes to exhibit reduced GPX4 levels compared to insulin 
sensitive counterparts [87]. On the other hand, GPX1 can be said to be a general hydrogen 
peroxide scavenger and may decrease H2O2 levels to a level detrimental to the cell [75] [76]. In 
fact, it has been shown by multiple studies for increased GSH levels to actually reduce insulin 






Figure 1.3: Generation of ROS in the mitochondria and antioxidant elimination of ROS 
[89]. (A) The electron transport chain consists of 5 complexes of which electrons are transferred 
to molecular oxygen. Electrons may leak during transport down the ETC, leading to superoxide 





Antioxidant Response Regulation 
As mentioned earlier, ROS serves as important signaling mediator at physiologic and 
pathological levels. Cellular antioxidant response is regulated by several different transcription 
factors including nuclear factor erythroid 2-like 2 (NFE2L2) and the forkhead box, class O 
(FOXO) family of factors. Transcription factors of the FOXO family allow for the production of 
antioxidant proteins in different cellular compartments including the mitochondria. However, 
FOXOs are also regulated and affected by ROS and other stressors such as fasting which can 
modulate FOXO activity [90]. Some of the FOXO-targeted genes include SOD2, catalase, 
Prx3/Prx5, Trx2, and TrxR2, which were mentioned earlier to play a vital part in mitochondrial 
ROS protection. The activity of FOXOs is regulated by several means of post-translational 
modifications, including acetylation [91]. Under conditions of oxidative stress, FOXOs can 
become acetylated which modulates its promoter selectivity. Acetylated FOXOs can interact 
with SIRT1, which has been shown to increase antioxidant response abilities of FOXOs [91] 
[92], yet decrease another one of FOXOs abilities, cell death. This modulation of FOXO activity 
has been suggested to allow cells to survive during elevated levels of oxidative stress. The 
importance of FOXOs has been further supported by studies showing its role in SIRT1-
dependent β-cell protection and insulin synthesis/secretion preservation [93], as well as oxidative 
stress protection in heart failure models [94]. In relation to adipose tissue, SIRT-dependent 
deacetylation of FOXOs, mainly FOXO1 in adipose tissue, has been shown to display an 
inhibitory effect on preadipocyte differentiation, which would ultimately affect adipose tissue 
mass and health as mentioned previously [95]. Furthermore, hyperactivation of FOXOs in 
obesity and diabetes has been associated with hyperglycemia, hyperlipidemia, and insulin 
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resistance [96]. It stands to reason that the interaction between FOXOs and oxidative stress play 
an important role in the development of adipocyte dysfunction, obesity, and metabolic syndrome. 
Normally Nrf-2 is sequestered in the cytoplasm until increases in oxidative stress trigger 
its translocation to the nucleus. Here it binds and activates the ARE (antioxidant response 
element) pathway, inducing transcription of antioxidant genes including heme oxygenase-1 (HO-
1), thioredoxin reductase, PRDX1, GPX, glutathione-S-transferase (GST), glutathione-S-
reductase (GSR), glutamate-cysteine ligase (GCL) NAD(P)H: quinone oxidoreductase-1 
(NQO1) [97]. In relation to adipose tissue, there’s conflicting evidence as to NFE2l2’s effects on 
adipogenesis being inhibitory or stimulatory [98] [99], however these studies utilized different in 
vitro models which may owe to opposing observations. IN HFD-mouse models, NFE2l2 does 
seem to play an inhibitory role on adipogenesis, as NFE2l2 KO mice displayed less fat mass, and 
smaller adipocytes that were also greater in number, suggesting a beneficial effect of 
adipogenesis here in the absence of NFE2l2 [98] [100]. However, NFE2l2 has also shown a vital 
role in maintaining mitochondrial health as it has been shown to enhance mitochondrial 
biogenesis [101]. More studies are needed to elucidate the dual effects of NFE2l2 on 
mitochondrial health and adipogenesis in the context of obesity and the metabolic syndrome. 
 
Exercise Effects on Obesity, Metabolic Health, and the Mitochondria 
Obese, metabolically unhealthy individuals display a loss of metabolic fitness which can 
manifest as reduced HDL-c, raised triglycerides, cholesterol, blood pressure, fasting plasma 
glucose, and a large waist circumference [2] [1]. Furthermore, loss of metabolic fitness has been 
found to be a strong predictor for cardiovascular disease (CVD), especially low HDL-c 
concentrations and elevated LDL-c concentrations [102] [103] [104]. One of the first approaches 
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to managing obesity, CVD and many diseases of the metabolic syndrome is diet and exercise, the 
latter of which has been shown in a number of studies to decrease weight and improve metabolic 
health [102] [105] [106] [107]. Some of these improvements include preventing and treating the 
aforementioned cardiovascular risk factors [108] [109] [110] [111] [112]. 
The exact mechanisms owing to the beneficial effects of exercise are still being 
elucidated, however much evidence points to improvements in mitochondrial health. Some of 
these exercise-related benefits include increased mitochondrial biogenesis, decreased PTP 
susceptibility, and an increase in Bcl-2 family of proteins, ultimately attenuating cell death [113] 
[114] [115] [116]. 
 
Conclusion 
Despite the numerous studies linking mitochondrial dysfunction, adipocyte dysfunction, 
obesity, and the metabolic syndrome, few have examined the role of FA, which are elevated in 
adipocyte dysfunction, on preadipocytes. Furthermore, the lipotoxic mechanisms by which FAs 
cause mitochondrial dysfunction may be a linking event to the aforementioned events and need 
to be elucidated. This dissertation will seek to address this deficiency in knowledge by utilizing 
human primary preadipocytes and examining their mitochondrial response to elevated 
physiologic FA exposure. I aim to further elucidate the mitochondrial mechanism of FA-induced 
toxicity, and further the understanding of the structure of the PTP. These findings may have 
over-reaching impacts on not only adipose health and the development of metabolic syndrome, 
but also on other energy imbalance-related diseases. 
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ABSTRACT 
Mitochondrial inner membrane (MIM) permeability transition is critical for the loss of 
bioenergetic efficiency in preadipocytes exposed to elevated fatty acid (FA) levels. Recently, it 
has been shown that the permeability transition pore (PTP) forms from within the F1F0ATP 
synthase complex under conditions of oxidative stress. It has been suggested that this transition 
involves F1F0ATP synthase acetylation, cyclophilin D (CypD) binding, and the release of the 
prosurvival Bcl-2 family members Bcl-2 and Bcl-XL. We report that primary human 
preadipocytes display a range of sensitivity to these events induced by FA. MIM 
permeabilization and ATP-depletion were prevented similarly by mitochondrion-selective 
antioxidants, as well as cyclosporin A, which uncouples CypD from the PTP, in both FA-
resistant (FAR) and FA-sensitive (FAS) preadipocytes. Although ABT-737, which prevents Bcl-
2 and Bcl-xL to interact with other proteins, brought down ATP levels of the FAR preadipocytes 
to the levels of FAS preadipocytes, it only marginally affected MIM permeabilization and cell 
viability. Mitochondrial acetyl-CoA accumulation was higher in FA-exposed FAS preadipocytes. 
Finally, sufficient F1F0ATP synthase acetylation leads to similar MIM permeabilization in the 
FAS cells and can only be reached in the FAR preadipocytes in the presence of mildronate, a 
gamma-butyrobetaine hydroxylase and carnitine acetyltransferase (CRAT) inhibitor. However, 
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totally preventing F1F0ATP synthase acetylation with L-carnitine was insufficient in totally 
preventing MIM permeabilization and cell death. Finally, FA exposure led to an increase in the 
expression of CRAT and sirtuin 3 (SIRT3). Altogether, these results presented suggest that FA 
sensitivity is partly regulated at the level of steady state levels of acetyl-CoA or deacetylation of 




Adipose tissues are endocrine and metabolic organs essential to systemic metabolic health, 
and considerable evidence suggests that adiposopathy, or moribund adipose tissue, is central to the 
pathogenesis of type 2 diabetes [117] [118] [119] [120]. In that respect, failure of adipose tissue 
to accommodate for chronic caloric excess through preadipocyte proliferation and/or 
differentiation has been hypothesized to have negative systemic metabolic consequences [120] 
[121] [13]. In support of this hypothesis are many studies showing evidence of decreased 
adipogenesis in patients that are insulin resistant [27] [122] [123]. Also supporting this hypothesis 
are studies showing decreased preadipocyte number in adipose tissue of subjects with obesity, 
which is further decreased in individuals that are prediabetics or diabetics [124] [125]. 
Notwithstanding that the underlying mechanisms for a correlation between reduced ability of 
preadipocytes to differentiate and a loss of metabolic health are still not fully understood, to 
understand the consequences of positive energy imbalances in preadipocytes is of importance. 
The range of fatty acid (FA) concentration to which preadipocytes are exposed daily is 
somewhat impossible to determine. However venous plasma nonesterified FA concentrations raise 
from nadir to more than 1000µM during the post-absorptive to postprandial transition and is 
maintained at least that high during fasting in subjects with or without type 2 diabetes [126]. 
Therefore, it is reasonable to speculate similar or higher adipose tissue interstitial FA levels during 
postprandial and fasting conditions. Palmitate-induced injury in human preadipocytes has been 
reported [127]. More recently, a study using prolonged exposure to a physiologically relevant 
mixture of FAs identified mitochondrial inner membrane (MIM) permeabilization and ATP 
depletion as critical steps to the cytotoxic effects of FAs [27].  
MIM permeability transition is defined as an increase in MIM permeability to ions and 
solutes of small molecular weight that dissipate the MIM potential and slowdown ATP 
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regeneration. MIM permeability transition is due to the formation of the mitochondrial 
permeability transition pore (PTP), which can be triggered by FAs, thiol oxidants, or elevated 
mitochondrial matrix calcium [31] [128]. One of the best characterized components of the PTP is 
cyclophilin D (CypD), which is involved in oxidative stress-triggered and calcium dependent MIM 
permeabilization [47] [41]. More recently the F1F0ATP synthase has emerged as the core 
component of a calcium-activated channel indistinguishable from the PTP [45] [129]. 
Interestingly, CypD was previously found to interact with the oligomycin sensitivity conferral 
protein (OSCP) subunit of F1F0ATP synthase and to decrease its ATP synthetic efficiency [44]. 
This interaction, which can be disrupted with cyclosporine A (CsA) or the OSCP-interacting drug 
Bz-423, was found to be responsible for F1F0ATP synthase transition to its PTP mode [45].  
Acetylation of CypD at lysine 166 has been shown to regulate CypD-dependent PTP 
occurrence, and mitochondrial dysfunction [130] [131]. Reciprocally, acetylation of OSCP lysine 
70 confers CypD sensitivity to the PTP [132]. Finally, another F1F0ATP synthase interacting 
protein is b-cell lymphoma extra-large (Bcl-xL) [59]. Bcl-xL binds the β subunit of the F1F0ATP 
synthase which confers ATP synthetic efficiency and conversely reduces CypD- and calcium-
dependent PTP formation [59] [129].  
           The mechanisms responsible for the decreased number of preadipocytes and/or reduced 
adipogenic potential in adipose tissue of patients with systemic insulin-resistance are unknown.  In 
this study we investigated the role of CypD, Bcl-xL, and mitochondrial acetylation levels in FA-
induced loss in ATP synthetic efficiency and MIM permeabilization.  
 
Materials and Methods 
CABG Patient Enrollment 
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Approval for this study was granted by the Institutional Review Board of the Brody School 
of Medicine at East Carolina (UMCIRB 09-0669). A total of 16 patients undergoing coronary 
artery bypass graft between November 2014 and January 2016 were enrolled.  
 
Primary Preadipocyte Isolation 
Following sternotomy, a small sample of subcutaneous adipose tissue was collected and 
immediately minced in Dulbecco's modified Eagle's medium (DMEM):F12 (1:1; Hyclone, 
Thermo Scientific, Logan, UT) containing 10mM glucose, 1mM pyruvate, 33μM Biotin, 17μM 
D-Pantothenate (all from Sigma Aldrich St. Louis, MO). Thereafter this medium will be referred 
to as the base medium. Upon arrival in the laboratory, the tissue was transferred to a tube 
containing the base medium completed with 1% fatty acid (FA)-free bovine serum albumin (BSA; 
Gemini Bio-Products) and 1 mg/mL of type 1 collagenase (Worthington, Lakewood, NJ). After 
being further minced the tissue was digested for 60-75 min at 37˚C and agitated at 120 rpm. The 
larger debris were trapped via filtration through a 420 µm filter. This filtrate was centrifuged at 
300g for 10 min, the mature fat cells aspirated, and the pellet suspended in 10mL of an erythrocyte 
lysis buffer composed of 154mM NH4Cl, 10mM KHCO3 and 0.1mM EDTA, which eliminated 
most erythrocytes within 3 to 6 min. This incubation was stopped by adding 40mL of base cell 
culture medium, filtered through a 100μm filter and centrifuged at 300g for 10 min. The resulting 
pellet was suspended in 2mL of base cell culture medium containing 10% fetal bovine serum, 1μM 
epidermal growth factor, 1μM basic fibroblast growth factor, 100nM insulin, and 10nM 
hydrocortisone (growth factors and serum were from Gemini Bio-Products, West Sacramento, CA; 
insulin was from Sigma-Aldrich, St-Louis, MO). This was considered passage zero (0) and cells 
were cultured for four to eight passages before their use.  
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Most experiments were performed at passage 3 to 6. None were done pass passage 8, as 
preliminary experiments performed on successive passages established that passage 8 is when 
markers of senescence are significantly upregulated. Between 1 to 3 hr prior to the experiments, 
the medium was replaced by DMEM containing 5% of calf serum, 25mM Hepes, 10mM glucose, 
reduced level of pyruvate (0.5mM), and 600μM FA-free BSA. We will thereafter refer to this as 
the experimental medium.  
 
Preparation of Fatty Acids 
All 50mM FA stock solutions (all FAs were from Sigma Aldrich) were prepared as 
previously described [27] [132].  These individual stocks were used to prepare the 2000μM (2X) 
working mixture prepared in the experimental medium. The FA proportion of this mixture was 
oleic acid (40%), palmitic acid (25%), linoleic acid (20%) and stearic acid (15%). One vol. of this 
2X mixture was added to cells already in 1 vol of the experimental medium containing, or not, the 
appropriate inhibitors at the onset of the incubations. The final FA to BSA ratio was 1.67:1. Based 
on the binding characteristics of the various fatty acids with BSA, the total free FA concentrations 
of our mixture was ~11nM with no individual fatty acid reaching concentrations above 5nM [133]. 
 
Determination of FA-Induced Cell Death  
Cells were maintained in the experimental medium until 30 min prior to the addition of 
FAs, which is the time at which they received either the appropriate inhibitor which included 5nM 
ABT-737, 500μM L-carnitine, 10μM Cyclosporine A (CsA), 100µM mildronate, 1nM MitoQ, 
10µM MitoTempo or the solvents (control). All these reagents were from the best commercial 
source except MitoQ, which was a gift from Michael P. Murphy (MRC Mitochondrial Biology 
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Unit, Cambridge, UK). These preincubations were followed by a 24 hr incubation with either the 
experimental medium (BSA) or 1000µM of the FA mixture described above. At the end of the 24 
hr incubation period, cells were collected with enzyme-free cell dissociation solution (Millipore 
Sigma) and incubated for 15 min at room temperature in Dulbecco’s phosphate-buffered saline 
(DPBS) containing calcein AM and ethidium homodimer 1 at a final concentration of 0.1μM [134]. 
The number of live and dead cells was evaluated by measuring calcein AM and ethidium 
homodimer-1 fluorescence (Thermo Fisher Scientific, Pittsburgh, PA) by flow cytometry (BD 
Accuri Cytometers, Ann Arbor, MI, USA). Calcein AM is a live cell dye that is non-fluorescent 
and accumulates in intact healthy cells, where it acquires a strong green fluorescence upon 
cleavage by intracellular esterases [134]. Because intracellular esterase activity is lost as cells die, 
little gain in fluorescence occurs in dying or dead cells. To detect calcein AM we used at an 
excitation wavelength of 488 and a 530 ± 30nm emission filter. For ethidium homodimer 1 we 
used an excitation wavelength of 488 and a 675 ± 25nm emission filter. Ethidium homodimer-1 is 
a dye that enters damaged plasma membranes and interacts with nucleic acids [134]. As this 
interaction increases, an increase in fluorescence indicates dying or dead cells. In each experiment 
100 % cell death was established by treating the cells with 100 % methanol and FA-induced cell 
death was obtained by subtracting the values obtained with BSA alone. Each of the measurement 
was performed in triplicate. 
 
Measurement of Mitochondrial Inner Membrane Permeabilization 
Cells were treated as described above. At the end of the 24 hr incubation period, the cells 
were lifted from the dish with the enzyme-free cell dissociation solution described above and 
incubated at 37°C with 0.1μM calcein AM in DPBS for 30 min, followed by 200μM CoCl2 for 15 
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min. Mitochondrial inner membrane (MIM) permeabilization was evaluated by measuring cobalt-
quenched calcein fluorescence by flow cytometry [135]. This is because calcein AM has access to 
most cellular compartments including the mitochondria.  However, cobalt (CoCl2) which quenches 
calcein fluorescence does not freely enter mitochondria unless rendered permeable due to 
permeability transition [135]. Calcein AM fluorescence was measured at an excitation wavelength 
of 488nm and emission through a 535 ± 30nm filter. The percent of cells experiencing quenching 
of calcein fluorescence was calculated by subtracting the histogram plots in the presence of calcein 
AM from the one obtained in its absence. Each of the measurement was performed in triplicate. 
 
Measurement of Cellular Respiration 
7,200 preadipocytes were seeded to each well of Seahorse XF96 plates (Seahorse 
Bioscience, Agilent Technology, Wilmington, DE) in basal cell culture medium without growth 
factor and grown at 37°C for 24 hr. 1 to 3 hr before the experiments, the medium was changed to 
the experimental medium. Cells were maintained in the experimental medium until 30 min prior 
to the addition of FAs, which is the time at which they received either the appropriate inhibitor or 
the solvents. These preincubations were followed by a 24 hr incubation with either BSA or 
1000µM FAs. At the end of the 24 hr incubation period, cells were washed two times with 250μL 
phosphate-buffered saline containing magnesium and calcium. Finally, 175μl of Seahorse assay 
media containing 10mM glucose, 2mM glutamine, 1mM pyruvate was added to the cells about 1 
to 2 hr before the XF96 assay was run (Seahorse Bioscience, Agilent Technology, Wilmington, 
DE). The measurement cycle consisted of 1 minute mix; 1 minute wait; and three minute 
measurements. Three basal cycles were performed, followed by 3 cycles after 1µM of oligomycin 
was injected, 3 after 750nM FCCP, and finally 3 cycles after 0.5μM rotenone.   
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To calculate ATP regeneration-driven respiration, oligomycin-resistant respiration was 
subtracted to basal respiration. To calculate uncoupled respiration, rotenone-resistant respiration 
was subtracted to oligomycin-resistant respiration. To calculate the respiratory reserve capacity 
basal respiration was subtracted to FCCP-elicited respiration. To account for the decrease in cell 
density we multiplied these oxygen consumption rates by the ratio of live cells (live cells in the 
control conditions/live cells in the presence of FA). Each of the measurement was performed in 
quadruplicate. 
 
Determination of ATP Concentration 
Cells were treated as described in the determination of FA-induced cell death section. At 
the end of the 24 hr incubation period, cells were washed twice with PBS and ATP was extracted 
by adding 200μL boiling water [123]. Following extraction, ATP levels were determined using a 
bioluminescence ATP determination kit (Life technologies) as described by the supplier. An 
Infinite 200 Pro Series plate reader was used to quantify the luminescence (Tecan, Morrisville, 
NC). 
 
Measurement of Mitochondrion-specific steady state levels of ROS 
Cells were treated as described in the determination of FA-induced cell death section. At 
the end of the 24 hr incubation period, cells were loaded with 4µM MitoSox (Invitrogen, Carlsbad, 
CA) for 30 min at 37˚C. After loading, the cells were washed in twice in DPBS and collected with 
enzyme-free cell dissociation solution before being suspended in DPBS. MitoSox Red 
fluorescence was measured by flow cytometry using an Accuri C6 at an excitation wavelength of 
488nm and a 585 ± 40nm emission filter., a hydroethidine-derived fluorescent probe coupled to 
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the mitochondria-derived hexyl triphenylphosphonium cation that detects mitochondrial matrix 
ROS, essentially superoxide [136].  
 
Mitochondrial Isolation from Preadipocytes 
Cells were grown in 500cm2 dishes in order to yield a sufficient number of cells for 
mitochondrial isolation. Cells were treated as described in the determination of FA-induced cell 
death section. At the end of the 24 hr incubation period, the following was performed in a 4˚C cold 
room, or on ice. Media was aspirated from the plates and plates were washed 2x with 25mL ice-
cold PBS. 15mL of PBS+10mM nicotinamide (Sigma Aldrich) was added and the cells were 
scraped from the plates and transferred to a 50mL microcentrifuge tube. The plates were scraped 
a second time after the addition of 10mL of PBS+nicotinamide and transferred to the same tube. 
Tubes were centrifuged at 1000g for 15 min and supernatant was discarded. Lysates were 
resuspended in 20mL of an ice-cold hypotonic buffer which consisted of PBS, 10mM NaCl, 
1.5mM MgCl2, 10mM TrisHCl, 500nM trichostatin A (TSA), 10mM nicotinamide, and a 100x 
protease inhibitor cocktail. Nicotinamide and TSA are deacetylase inhibitors and were added to 
prevent the deacetylation of mitochondrial proteins which was later assessed. Working 
concentrations of our protease inhibitor cocktail included 400µM aprotinin, 50µM bestatin, 10µM 
E64, 50µM leupeptin, with 2000x pepstatin and 100xPMSF being added to the cocktail the day of 
experiments. 
The resuspended cells sat on ice for 5 minutes and were then homogenized 10 times via a 
Dounce homogenizer, checking for complete homogenization. 1/3 volume of mitochondrial 
homogenization buffer was added which consisted of PBS, 500nM TSA, 10mM nicotinamide, 
100x protease inhibitor cocktail, and 50mM sucrose. Samples were then centrifuged at 800g for 
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10 min which yielded a nuclear pellet and the supernatant containing mitochondria. The 
supernatant was transferred to an ice-cold microcentrifuge tube and centrifuged at 17,000g for 15 
min, yielding the mitochondrial pellet. The supernatant was carefully aspirated to not disturb the 
pellet, and the pellet was resuspended in 250µL of isolation buffer which consisted of PBS, 1% 
dodecyl maltoside, .5mM EDTA, 150mM TrisHCl, 150mM NaCl, 500nM TSA, 10mM 
nicotinamide, and 100x protease inhibitor cocktail. Protein concentration was measured via a BCA 
Protein Assay Kit (Thermo Fisher Scientific) and samples frozen at -80˚C until further use. 
 
Measurement of Mitochondrial Acetyl CoA 
Cells were treated as described in the determination of FA-induced cell death section. At 
the end of the 24 hr incubation period, mitochondria were isolated from primary preadipocytes as 
previously described. Samples were deproteinated through a 10 kDa spin column and centrifuged 
at 4˚C at 10,000g for 10 min. Supernatant was collected and acetyl CoA levels were measured 
according to PicoProb Acetyl CoA Flurometric Assay kit and protocol (BioVision). Fluorescence 
was assessed by an Infinite 200 Pro Series plate reader (Tecan, Morrisville, NC). 
 
Evaluation of F1F0 ATP synthase acetylation 
Cells were treated as described in the determination of FA-induced cell death section. At 
the end of the 24 hr incubation period, cells were washed twice with DPBS and lysed in non-
denaturing condition. The lysing buffer was DPBS-based and contained 1% of Halt Protease 
Inhibitor Cocktail (Thermo Fisher Scientific), 0.5% IGEPAL (Sigma Aldrich), and 10mM 
nicotinamide. The protein concentration was quantified using a BCA Protein Assay Kit (Thermo 
Fisher Scientific) and standardized to 1 mg/mL. The F1F0 ATP synthase complex was purified by 
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incubating this lysate overnight on a Rotator at 4˚C with 20μL of an ATP Synthase-Agarose Beads 
Immunocapture Antibody (Abcam, Cambridge, MA). The next morning the samples were 
centrifuged at 500g for 1 min, and supernatant discarded. The pelleted beads were washed three 
times with 1mL of the immunoprecipitation buffer. The pulled down F1F0 ATP synthase complex 
was eluted from the beads by adding 60µL of 1.5X Laemmli loading buffer containing 1.5% 
sodium dodecyl sulfate (both from Biorad Life Sciences Research, Hercules, CA), mixing gently 
for 10 min, and filtering through Ultrafree-MC-SV centrifugal filter units (Millipore Sigma) by 
spinning the units at 500g for 3 min.  The samples from this step were loaded on Mini-protean 
TGX 4%-20% gels (Biorad Life Sciences), transferred to nitrocellulose membranes (GE 
Healthcare Bio-Sciences, Pittsburg, PA), and immunodetected using antibodies specific for acetyl-
lysine (Sigma Aldrich), Cyclophilin D (Thermo Fisher Scientific), Bcl-xL (Cell Signaling), and 
ATPB5 (Sigma Aldrich). 
 
Gene Expression Analysis 
Cells were treated as described in the determination of FA-induced cell death section. At 
the end of the 24 hr incubation period, cells were washed twice with DPBS and lysed in 1mL TRI-
Reagent (Sigma Aldrich) and frozen at -80˚C until RNA isolation. On the day of isolation 1 vol of 
ethanol was added to the samples and they were loaded to Zymo-Spin IIC columns, washed, and 
eluted as described in the Direct-Zol RNA MiniPrep Isolation kit (Zymo Research, Irvine, CA). 
cDNA was synthesized from 2µg total RNA according to the High Capacity cDNA Reverse 
Transcription kit protocol (Applied Biosystems, Forest City, CA). Relative real-time TaqMan PCR 
was performed with primers and 6-carboxyfluorescein dye-labeled TaqMan probes (Applied 
Biosystems). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as endogenous 
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control. This control was validated in a comparison with 18S, HPRT, and POLII as it was found 
to be the most stable among the samples. Each reaction contained 5ng cDNA from total RNA, in 




16 subjects, 10 males and 6 females were enrolled in this study whom underwent a coronary 
artery bypass graft surgery and consented to a small (less than a gram) subcutaneous fat biopsy. 
They were all middle aged (49 to 69 years old), half were African American, and half were 
European American, 9 were obese and 7 were diabetic. This study was about the molecular 
mechanisms of preadipocyte sensitivity to fatty acids (FAs) and no attempt were made to reach 
clinical correlates.  
 
Preadipocytes Isolated from Sixteen Individuals Differ in Their Susceptibility to the 
Lipotoxic Effects of Prolonged Fatty Acid (FA) Exposure. 
We first set out to determine if preadipocytes isolated from the upper abdominal 
subcutaneous adipose tissue of 16 individuals differed in their sensitivity to a 1000 µM mixture of 
FAs composed of oleic acid (40%), palmitic acid (25%), linoleic acid (20%) and stearic acid (15%) 
for a duration of 24 h. This FA mixture roughly mimics physiological FA composition while the 
concentration of 1000 µM is in the range of concentrations seen in adipose tissue during 
postprandial and fasting conditions [126]. In addition, this concentration and incubation time was 
chosen from the results of our previous study, which established that mitochondrial inner 
membrane (MIM) permeabilization start to occur following 12 h FA treatment, while cell death 
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takes place between 18 to 24 h of FA exposure [27]. As shown in Fig. 1A, the mean percent of FA-
induced cell death ± SD was 8.1 ± 1.9 for the lowest, or FA-resistant quintile (FAR), and 27.8 ± 
3.2 for the highest, or FA-sensitive (FAS), quintile (P ≤ 0.0001). As shown in Fig. 1B, the 
preadipocytes from the FAR group also displayed less MIM permeabilization as 13.3 ± 0.2 percent 
did compared to 30.1 ± 2.0 in the FAS group.   
 
Intramitochondrial Superoxide or Lipid Peroxides are Responsible for FA-Induced ATP 
Depletion, MIM Permeabilization and Cell Death.   
A transient increase in the steady state levels of superoxide and/or lipid peroxides was 
shown in a preadipocyte cell line to be required for FA-induced MIM permeabilization, ATP-
depletion, a second and more substantial wave of ROS production that spills out of the 
mitochondria, and eventually cell death [27]. We first evaluated the impact of prolonged FAs 
exposure in both FAS and FAR primary preadipocytes. As shown in Fig. 2A, despite being 
significant in both groups, FA-induced a 4.5-fold higher (P ≤ 0.001) increase in mitochondrial 
ROS in the FAS group (90 vs 20 %). FAs also led to more severe (P ≤ 0.05) ATP depletion in FAS 
(64%) than FAR (36%) preadipocytes (Fig. 2B). Next, we assessed the role mitochondrial 
superoxide and/or lipid peroxides in FA-induced ATP depletion, MIM permeabilization, and cell 
death. To this end, we incubated the cells with MitoQ or MitoTempo, two mitochondrion-targeted 
superoxide and lipid peroxide scavengers. First, as shown in Fig. 2C, FA-induced mitochondrial 
ROS production was almost totally (78-93%) prevented by the two scavengers. Surprisingly, FA-
induced ATP-depletion was not only prevented but reached levels 40 to 104% above control 
conditions (Fig. 2D). MitoQ and MitoTempo also prevented 75-84% of FA-induced MIM 
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permeabilization (Fig 2E) and 87-91% of FA-induced cell death (Fig 2F) in both FAS and FAR 
without distinction. Suggesting similar mechanisms of FA-induced cytotoxicity in both groups.    
 
Cyclophilin D (CypD) Interaction with the Mitochondrial Permeability Transition Pore 
(PTP) is Implicated in FA-Induced Cytotoxicity in Preadipocytes. 
Cyclosporin A (CsA), a well know PTP inhibitor, has been shown to prevent the interaction 
between CypD and F1F0ATP synthase, preventing the formation of the PTP [132]. Confirming this 
finding in our preliminary experiment showed that 10 μM CsA, a concentration we established to 
have no impact on basal MIM permeability (Suppl. Fig. 1A), prevented FA-induced MIM 
permeabilization by about 75%, and displaced CypD from F1F0ATP synthase (Suppl. Fig. 1B). 
Therefore, preadipocytes were preincubated with or without 10 μM CsA for 30 min and co-
incubated 24 h with FAs. As shown in Fig. 3A. CsA decreased FA-induced ROS production by 
64% in the FAR and 96% in the FAS group. Similarly, to MitoQ and MitoTempo, CsA not only 
prevented ATP depletion, but increased ATP concentration above (57-66%) control levels (Fig. 
2B). CsA prevented FA-induced MIM permeabilization by 42% in FAR preadipocytes and 72% 
in FAS preadipocytes (Fig. 3C). CsA also prevented FA-induced cell death by 41% in FAR 
preadipocytes and 69% in FAS preadipocyte (Fig 3D).  
 
Inhibition of Bcl-2 and/or Bcl-xL Exacerbates FA-induced Toxicity in FA-Resistant 
Preadipocytes 
ABT-737 is potent inhibitor of Bcl-2, Bcl-xL and Bcl-w [137]. These Bcl-2 family 
members are well known for their role as regulators of the mitochondrial pathways of various types 
of regulated cell death. In addition, Bcl-2 was shown to directly interact with the respiratory 
38 
 
complex IV, which was shown to reduce superoxide production [138]. Bcl-xL, on the other hand, 
was shown to interact with the F1F0 ATP synthase complex, reducing proton leak and increasing 
ATP regeneration efficiency [59]. Our preliminary experiments confirmed the presence of Bcl-xL 
in the F1F0 ATP synthase complex and showed that this interaction is decreased by 85% after 24 
h of exposure to FAs (Suppl. Fig. 2A). Therefore, preadipocytes were preincubated with or without 
5 nM ABT-737, a concentration that did not affect basal steady state levels of ATP (Suppl. Fig. 
2B), but exacerbated FA-induced increases in the steady state levels of mitochondrial ROS by 20% 
in the FAS and by 138% in the FAR group (Fig. 4A). This increase in mitochondrial ROS in the 
FAR group was 50% of what was seen in the FAS group (P ≤ 0.001). Despite this, ABT-737 
exacerbated the FA-induced ATP depletion in the FAR group only as the depletion became 
undistinguishable between the two groups (Fig. 4B). ABT-737, exacerbated FA-induced MIM 
permeabilization by 16% in the FAS and 55% in the FAR group (Fig. 4C). Finally, ABT-737 
increased FA-induced cells death in FAR, but not FAS, preadipocytes (Fig. 4D). 
 
The Respiratory Reserve Capacity of Preadipocytes is Higher and FAs Induce Uncoupling 
in FAR Preadipocytes Only. 
We next assessed the impact of ABT-737 or CsA treatment on the effects of 24 h of FA 
exposure on the mitochondrial health of preadipocytes. To this end, preadipocytes were 
preincubated with or without 5 nM ABT-737 or 10 μM CsA for 30 min and incubated 24 h with 
FAs. As shown in Fig. 5A, incubating the cells with FAs add no effect on basal respiration. 
However, FAs induced an increase in respiration in the presence of 1 μM oligomycin, meaning 
that it increased oxygen consumption while uncoupled to ATP regeneration (Fig. 5B). This 
increase in uncoupling was totally prevented by ABT-737 (Fig 5B). Interestingly, the respiratory 
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reserve capacity, which indicates how close the cells are to their maximal capacity, was 3 times 
greater (P ≤ 0.01) in FAR compared to FAS preadipocytes (Fig. 5C). In the presence of FAs and 
ABT-737 this difference between the two groups was gone (Fig. 5C).  
 
FAs Cause a Further Increase in Acetyl-CoA and F1F0 ATP Synthase Acetylation in FAS 
Preadipocytes and Increase the Expression of L-Carnitine Acetyltransferase (CRAT) and 
sirtuin 3 (SIRT3) in FAS Preadipocytes Only.  
The role of mitochondrial protein acetylation was shown to influence mitochondrial 
functioning and SIRT3 ablation to cause protein hyperacetylation and metabolic abnormalities 
[62]. Moreover, mitochondrial protein acetylation was shown to be driven by FA oxidation-
derived acetyl-CoA [139]. Since the effects of acetyl-CoA are concentration dependent and 
regulated by CRAT [140], we tested the effects of two drugs with opposite effects on acetyl-CoA 
levels. First, we treated the cells with 500 μM L-carnitine, which should reduce the pool of 
activated acetyl groups by promoting acetylcarnitine efflux [63]. Second, we treated the cells with 
100 μM mildronate, an inhibitor of both gamma-butyrobetaine hydroxylase, a key enzyme in L-
carnitine synthesis and CRAT, which should increase acetyl-CoA levels [141] [142].  
As shown in Fig. 6A, mitochondrial acetyl-CoA levels were increased in both FAS and 
FAR preadipocytes, although the increase in the FAR group was 20% smaller (P ≤ 0.001). 
Moreover, although L-carnitine significantly prevented the increase in acetyl-CoA in both groups, 
it only was prevented fully in the FAR group (Fig. 6A). On the other hand, mildronate led to a 
further increase in acetyl-CoA in the FAR only (Fig. 6A). Similarly, there was increased 
acetylation of many proteins within the F0F1 ATP synthase complex (Fig. 6B). However, although 
it did not fully prevent the increase in acetyl-CoA, L-carnitine totally prevented the increase in 
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acetylation of the F0F1 ATP synthase complex (Fig. 6B). FA-induced MIM permeabilization, in 
the same conditions, was decreased by 71% in the FAR and 60% in the FAS group (Fig. 6C), and 
cell death by 60% in both groups (Fig. 6D). However, despite similar relative deceases in MIM 
permeabilization and cell death, the remaining MIM permeabilization and cell death in the FAS 
group was still significantly above the control basal BSA condition (P ≤ 0.001) for both endpoints.  
Finally, we evaluated the effect of 24 h FA exposure on the expression of SIRT1, SIRT3 
and CRAT. As sown in Fig. 6E, FA exposure had opposite effects on the expression of SIRT3 and 
CRAT, increasing the levels of their mRNA in FAR by 56 and 146% respectively, but decreasing 
by 30 and 65% respectively in FAS preadipocytes.   
 
DISCUSSION 
This study was performed to investigate the role of CypD, BCl-2 or Bcl-xL, and 
mitochondrial acetyl-CoA levels in FA-induced loss of ATP synthetic efficiency, MIM 
permeabilization, and cell death. First, we found a 3.5-fold range of FA-induced MIM 
permeabilization and cell death in primary culture of human preadipocytes. However, it was 
beyond the scope of this study to establish clinical correlates from these observations as this study 
would be severely underpowered for such type of analysis. However, we systematically compared 
the FAR and FAS preadipocytes as it had the potential to suggest the molecular mechanism 
underlying this difference in sensitivity.  Our main conclusion is that mitochondrion-generated 
ROS and CypD are central to FA-induced MIM permeabilization, loss in ATP regeneration 
capacity, and cell death. This mechanism appears to be shared in FAR and FAS sensitive 
preadipocytes as MitoQ and MitoTempo treatments totally eliminate MIM permeabilization, ROS 
production and cell death.  
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One interesting finding was the increase, rather than the normalization of the steady state 
levels of ATP after a pretreatment with MitoQ and MitoTempo as well as CsA. Recycling ATP 
from ADP•Mg2+ and Pi is the day job of the mitochondrial F1F0 ATP synthase.  Cellular levels of 
ATP are very stable, even in tissues with high fluctuations in ATP demand, which is the main 
driver for regeneration [143]. There are other factors that optimize electron and proton flow, which 
ultimately power the F1F0 ATP synthase, but none are more influential than the mitochondrial 
redox environment [144]. When FA levels exceed the reducing equivalent needed to maintain ATP 
turnover, the cells are under reductive pressure, a state in which ROS are produced at a rate 
somewhat superior to the buffering potential of the antioxidant system [145]. One possibility is 
that the shift in intramitochondrial redox environment caused by reductive pressure favors electron 
leak from complex I and III, and that the presence of MitoQ and MitoTempo prevent this redox 
break to occur.  
Among the plethora of components that have been proposed to be part of the PTP, CypD 
is the only one recognized as necessary [40]. CsA, which prevents CypD to bind to F1F0 ATP 
synthase [45], has also been shown to cause an increase in ATP levels. CypD binding to PTP was 
shown to be involved in both the reversible and short-lasting flicker-like opening, and the 
irreversible large conductance opening of the PTP [146]. This may explain what we observed as 
the flickering mode of the PTP reduces ROS production by serving as a valve that prevents the 
back pressure that opposes proton transfer to the intermembrane space and the buildup of the 
proton motive force.  
Contrary to what we observed in immortalized XA15A1 human preadipocytes [27], FAs 
did not reduce basal respiration driven by glucose, pyruvate, and glutamine. We can only speculate 
that the immortalized cells relied more on these substrates to maintain ATP regeneration during 
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proliferation [147]. However, FAs caused an increase in respiration uncoupled from the need for 
ATP regeneration in the FAR preadipocytes only. In a state of reductive pressure, uncoupling may 
be a beneficial adaptation [145], reducing ROS production.  This is in line with our mitochondrial 
ROS measurement as FAs only increased MitoSox Red fluorescence by 20-23% in FAR, as 
opposed to 90-96% in the FAS preadipocytes. The absence of an inhibitory effect of CsA on 
uncoupling suggests that this adaptive uncoupling process is not mediated by CypD and the PTP 
and could be possibly through more traditional uncoupling mechanisms involving uncoupling 
proteins [148]. However, the prevention of uncoupling by ABT-737 suggests that Bcl2, bcl-xL or 
even Bcl-w, can participate in this uncoupling. This would be consistent with the suggested role 
for Bcl-2 family members in FA-induced uncoupling in human adipocytes [149]. Also supporting 
a role for Bcl-2 family members in uncoupling is the exacerbation of FA-induced ATP depletion 
in ABT-737 treated FAR preadipocytes. FAR resistant preadipocytes also had a much higher 
reserve capacity, which was decreased by FA, and further exacerbated by ABT-737. Both of these 
effects of ABT-737 were accompanied by a parallel increase in cell death in FAR cells, suggesting 
that ATP depletion may partly cause cell death, and that the higher reserve capacity may be 
explaining the resistance to FA-induced cell death. 
We found that FAs caused an accumulation of acetyl-CoA in the mitochondria of both 
FAR and FAS preadipocytes, but F0F1 ATP synthase acetylation in FAR cells was 50% of what 
was measured in the FAS preadipocytes. This could be due the induction of SIRT3 in the FAR, 
but not FAS preadipocytes, as SIRT3 has been shown to deacetylate both the F0F1 ATP synthase 
[132] [150], and CypD [130] [131], to protect against nutrient-induced stress. However, total 
elimination of FA-induced F0F1ATP synthase acetylation with L-carnitine pretreatment prevented 
cell death by 60% in both FAR and FAS preadipocytes, suggesting that although CypD is 
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responsible for cell death, the difference in acetylation levels is not the sole reason for the 
difference in FA sensitivity.  
Altogether this study characterized the mechanism of FA-induced cell death in primary 
human preadipocytes. The mechanism being an increase in mitochondrial ROS production that 
leads to a CypD-dependent MIM permeabilization. PTP formation, the cause of MIM 
permeabilization and ATP depletion, is occurring at a higher rate in FAS than FAR preadipocytes. 
Although F0F1 ATP synthase acetylation is reduced in FAR preadipocytes, it only partly explains 
their sensitivity. Additionally, although FAS experience much more profound ATP-depletion, the 
latter is not the cause of cell death. It is likely that alternative ROS-dependent mechanisms are 






Race BMI A1C 
M F  White African American   
10 6 60.31 +/- 5.71 8 8 29.25 +/- 5.28 6.88 +/- 2.68 
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Figure 1. Preadipocytes isolated from the upper abdominal subcutaneous adipose tissue of 
16 subjects differ in their susceptibility to cytotoxic effects of fatty acids. Preadipocytes were 
incubated for 24 hr with 1000μM of fatty acids (FAs) and (A) the percent of dead and (B) percent 
of cell experiencing mitochondrial inner membrane (MIM) permeabilization were evaluated as 
described in the Materials and Methods section. The 1st and 5th quintiles were selected and termed 
fatty acid sensitive (FAS) and fatty acid resistant (FAR). The results were analyzed by one-way 
ANOVA followed with Dunnett’s as post hoc test. The first and last quintile was significantly 
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Figure 2. FA-induced mitochondrial reactive oxygen species (ROS) and ATP depletion are 
induced to a greater extent in FAS compared to FAR preadipocytes. Effect of the 
mitochondrion-targeted antioxidants MitoQ and MitoTempo on FA-induced mitochondrial 
ROS, ATP depletion, MIM permeabilization and cell death. Preadipocytes from the FAS and 
FAR groups were incubated for 24 hr with 1000 µM of FAs and (A) MitoSox Red fluorescence 
and (B) ATP levels were measured as described in Materials and Methods section. In (C to F) 
Cells were preincubated 10 min with or without 1 nM MitoQ or 10 µM MitoTempo for 10 min 
prior to 24 h with 1000 µM FAs and (C) MitoSox Red fluorescence, (D) ATP levels, (E) MIM 
permeabilization, and (F) cell death were measured. Results were expressed as the mean ±SD 
and analyzed by two-way ANOVA. * P≤0.05, ** P≤0.01, *** P≤0.001 compared to BSA (A, B) 






































































































































































































































Figure 3. Inhibiting cyclophilin D (CypD) binding to the F1F0ATP synthase with 
cyclosporin A (CsA) attenuates FA-induced toxicity in preadipocytes. Preadipocytes from 
the FAS and FAR groups were preincubated with or without 10µM CsA for 10 min prior to 24 hr 
with 1000µM FAs and (A) MitoSox Red fluorescence, (B) ATP levels, (C) MIM 
permeabilization, and (D) cell death were measured. Results are expressed as the mean ±SD and 
analyzed by two-way ANOVA followed by the Sidak pairwise multiple-comparison test. * 
P≤0.05, ** P≤0.01, *** P≤0.001 compared to FAs; +++ P≤0.001 comparing the FAS and FAR 










































































































































































































































Figure 4. Inhibiting b-cell lymphoma extra-large (Bcl-xL) binding to the F1F0ATP synthase 
with ABT-737 exacerbates FA-induced ROS production and ATP depletion in FAR 
preadipocytes, while marginally affecting MIM permeabilization and cell death. 
Preadipocytes from the FAS and FAR groups were preincubated with or without 5nM ABT-737 
for 10 min prior to 24 hr with 1000 µM FAs and (A) MitoSox Red fluorescence, (B) ATP levels, 
(C) MIM permeabilization, and (D) cell death were measured. Results are expressed as the mean 
±SD and analyzed by two-way ANOVA followed by the Sidak pairwise multiple-comparison 
test. * P≤0.05, *** P≤0.001 compared to FAs; +P≤0.05, +++ P≤0.001 comparing the FAS and 








Figure 5. FA-induced mitochondrial dysfunction in FAR and FAS cells. Inhibiting Bcl-xL 
exacerbated FA-induced dysfunction, whereas CypD inhibition attenuated FA-mediated 
changes in mitochondrial respiration. (A-C) Preadipocytes from the FAS and FAR groups 
were preincubated with or without 5nM ABT-737, or 10µM CsA for 10 min prior to 24 hr with 
1000µM FAs and mitochondrial respiration was measured via respirometry. At the end of the 24 
hour incubation basal, oligomycin-sensitive, FCCP-elicited and rotenone-sensitive respiration 
were measured. (A-C) ATP-regeneration driven, uncoupled, and reserve capacity were calculated 
according to the Materials and Methods section. Results presented in A-C were analyzed by two-
way ANOVA on repeated measures with Boneferroni’s as post hoc test. Results are expressed as 
the mean ±SD. * P≤0.05 compared FAs to BSA, $$ P≤0.05 compared to FA, ## P≤0.05 








Figure 6. FAs induce an increase in the steady state levels of acetyl CoA, F1F0 ATP synthase 
hyperacetylation, and increase in MIM permeabilization. These effects being more 
pronounced in the FAS compared to the FAR preadipocytes. Preadipocytes from the FAS 
and FAR groups were preincubated for 10 min with or without 500 μM L-carnitine or 100 μM 
mildronate prior to 24 hr with or without 1000 μM FAs. (A) Acetyl CoA levels were measured in 
isolated mitochondria as described in the Materials and Methods section. (B) F1F0 ATP synthase 
was immunoprecipitated and acetyl-lysine levels was evaluated by western blot as described in 
the Materials and Methods section. (C) MIM permeabilization and (D) cell death were measured 
as previously described. (E) mRNA expression of sirtuin 1 and 3 (SIRT1 and SIRT3) and L-
carnitine O-acetyltransferase (CRAT) was measured via real-time PCR as described in Materials 
and Methods section. Results are expressed as the mean ±SD and analyzed via two-way 
ANOVA with followed by the Sidak pairwise multiple-comparison test. ***P≤0.001 comparing 
BSA to FAs; + P≤0.05, ++ P≤0.01, +++ P≤0.001 comparing the FAS and FAR groups. $$ P≤0.01, 
$$$P≤0.001 comparing the FAs to Drug + FAs.  In (E) the results were analyzed with a paired t-
test. 005 compared to BSA control; ** P≤0.001 compared to FAs; + P≤0.05 comparing the FAS 









Supplemental Figure 1. CsA completely prevented CypD binding to the F1F0 ATP synthase, 
and had no impact on basal MIM permeability. Preadipocytes from the FAS and FAR groups 
were preincubated with or without 10µM CsA for 10 min prior to 24 h with 1000 µM FAs. (A) 
The F1F0 ATP Synthase was immunoprecipitated as described in Materials and Methods and 
western blots measured CypD binding to the F1F0 ATP synthase. (B) Preadipocytes were 










Supplemental Figure 1. FA displace Bcl-xL binding from the F1F0 ATP synthase, however 5 
nM ABT-737 doesn’t affect control steady state levels of ATP. Preadipocytes from the FAS 
and FAR groups were preincubated with or without 5nM ABT-737 for 10 min prior to 24 h with 
1000 µM FAs. (A) The F1F0 ATP Synthase was immunoprecipitated as described in Materials 
and Methods and western blots measured Bcl-xL binding to the F1F0 ATP synthase. (B) 
Preadipocytes were preincubated with or without 5 nM ABT-737, a concentration that did not 
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ABSTRACT 
Prolonged exposure of preadipocytes to concentrations of fatty acids (FAs) seen during 
prolonged fasting has been shown to be cytotoxic through mechanisms involving mitochondrial 
inner membrane (MIM) permeabilization and ATP depletion. Moribund preadipocytes have been 
suggested to be part of the pathogenesis of dysfunctional adipose tissue, which in turn, 
precipitates the appearance of cardiometabolic risk factors. Exercise training has been shown to 
impact metabolic organs including subcutaneous adipose tissue (SAT). To determine the effects 
of exercise training on the FA sensitivity of preadipocytes isolated from SAT we enrolled 35 
subjects (10 males/25 females) with obesity but normoglycemic in a 12-week aerobic interval 
training (AIT) exercise program and obtained abdominal and gluteal subcutaneous adipose tissue 
(SAT) biopsies at baseline and after the intervention. At baseline, FA sensitivity evaluated by 
measuring FA-induced MIM permeabilization and cell death spanned 4-folds and 
indiscriminately between the two tissues. Of the 28 subjects completing the training 22 improved 
their aerobic capacity (VO2peak), indicating that the training was efficient, and 25 improved their 
FA sensitivity. Training was also efficient at improving insulin sensitivity as well as decreasing 
total and low-density lipoprotein (LDL)-cholesterol.  
 
63 
We tested three hypotheses: 1) baseline FA sensitivity predicts who will benefit from 
AIT training; 2) AIT training improves preadipocyte FA sensitivity; 3) The improvement in FA 
sensitivity correlates with the decrease in cardiometabolic risk factors. We found that: 1) there is 
a trend for baseline FA sensitivity to correlate with the changes in triglycerides as well as HDL-c 
after training, despite the fact that the FA resistant subjects had a significant higher baseline 
HDL-c levels; 2) AIT improves preadipocytes FA sensitivity; 3) improvement in FA sensitivity 
correlates with reduction in total cholesterol and LDL-c. In conclusion, AIT improves 
cardiometabolic risk factors, and also improves the FA sensitivity of preadipocytes, but the 
usefulness of measuring FA-sensitivity as a predictor of who would benefit the most from AIT 




Obesity is considered to be caused by a combination of a high caloric diet and a lack of 
physical activity, resulting in a positive energy imbalance. If this imbalance exists chronically, it 
may also result in a loss of metabolic fitness which can manifest as reduced HDL-c, raised 
triglycerides, cholesterol, blood pressure, fasting plasma glucose, and a large waist 
circumference [2] [1]. Furthermore, loss of metabolic fitness has been found to be a strong 
predictor for cardiovascular disease (CVD), especially low HDL-c concentrations and elevated 
LDL-c concentrations [102] [103] [104]. One of the first approaches to managing CVD and 
many diseases of the metabolic syndrome is diet and exercise, the latter of which has been shown 
in a number of studies to decrease weight and improve metabolic health [102] [105] [106] [107]. 
Some of these improvements include preventing and treating the aforementioned cardiovascular 
risk factors [108] [109] [110] [111] [112]. 
The exact mechanisms of the beneficial effects of exercise are still being elucidated, 
however much evidence points to improvements in mitochondrial health [113] [114] [115]. The 
mitochondria have become a popular therapeutic target recently for an array of diseases, with the 
mitochondrial permeability transition pore (PTP) being at the center of a number of different 
pathological disorders. PTP is described as a large conductance pore that causes the collapse of 
the chemiosmotic gradient across the mitochondrial membrane (MIM), effectively halting ATP 
synthesis, and through prolonged opening, promoting cell death.  
Our previous findings showed that inhibiting PTP afforded cellular protection and 
preservation of mitochondrial health in human primary preadipocytes [27] [151]. Chronic 
positive energy imbalance and adipose tissue dysfunction, both hallmarks of obesity, result in 
elevations of FFA in adipose tissue and serum  [9] [27] [151]. Previous work in our lab has 
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found elevated FFA to cause an increase in the steady state levels of mitochondrial reactive 
oxygen species and lipid peroxides, which, in turn, cause delayed PTP, ATP depletion, and cell 
death in preadipocytes [27]. Additionally, we found for preadipocytes isolated from older 
patients undergoing CABG surgery to differ in their susceptibility to FA-induced toxicity [151]. 
In the present study we isolated primary subcutaneous preadipocytes from 
overweight/obese subjects participating in a 12-week exercise training regimen. Preadipocytes 
isolated prior to exercise were treated with a physiologically relevant FA cocktail to determine 
pre-exercise sensitivity to fatty acids, and their correlation to metabolic health markers. We 
hypothesized that 1) Subject FA-sensitivity (FAS) would correlate with pre-exercise metabolic 
health markers, being the higher the FA-induced toxicity, the worse the subject’s metabolic 
profile; 2) 12-week exercise training would decrease FAS and improve metabolic health; 3) Pre-
exercise FAS determination could be a predicative tool for the efficacy of exercise in managing 
obesity and cardiovascular risk factors. Our major findings were that subject pre-exercise FAS 
varied among young subjects, and this FAS correlated with decreased subject metabolic health; 
and 12-week exercise training improved this FA-sensitivity, along with lowering cardiovascular 
risk factors total cholesterol, and LDL-c. 
 
Materials and Methods 
Participants.  
Normoglycemic, obese (BMI > 30 kg/m2) men and women (ages 25-47) were recruited to 
participate in this study. Exclusion criteria were set as previously described [152]. All procedures 
were approved by the University and Medical Center Institutional Review Board of East Carolina 
University (UMCIRB 11-0262). 
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Anthropometrics, Assessment of Aerobic Capacity, and Blood Analyses 
Height was measured with a stadiometer to the nearest 0.1 cm; body mass was measured 
with a digital electronic scale to the nearest 0.05 kg. Body fat percentage was determined using 
dual-energy x-ray absorptiometry (DXA; GE Lunar Prodigy Advance, Madison, WI, USA) as 
previously described [153]. At baseline and after exercise training subjects performed a 
standardized maximal exercise test to assess peak aerobic capacity (VO2peak). VO2peak was 
assessed via open circuit spirometry (TrueMax 2400; Parvomedics; Salt Lake City, UT, USA) 
using the Storie protocol, a treadmill ramp protocol where the speed or incline is increased every 
2 min until volitional fatigue is reached. Heart rate (HR) was recorded every minute throughout 
the test and immediately upon fatigue to determine the maximum heart rate (HRmax). Before and 
after the training intervention a fasted blood draw was performed where blood was collected 
from the antecubital vein. Blood samples were allowed to clot and were then centrifuged at 3300 
rpm for 10 min. Serum glucose, insulin, triglycerides, total-cholesterol, and high-density 
lipoprotein cholesterol were assessed by a commercial laboratory (Laboratory Corporation of 
America). Low-density lipoprotein cholesterol was calculated by the Friedewald formula [154] 
and the homeostatic model of insulin resistance (HOMA-IR) was calculated as previously 
described [155].                         
 
Adipose Tissue Biopsies  
Abdominal and gluteal SAT biopsies were performed as previously described [156] after 
an overnight fast (≥10 h) at baseline and after 3 months of exercise training. SAT samples were 
immediately rinsed with Krebs Ringer Bicarbonate buffer, blood clots and blood vessels were 
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then removed. The biopsy sample was then minced and transported for cell isolation in DMEM-
F12. 
 
Aerobic Interval Training  
Participants performed an aerobic interval exercise training intervention 3d/wk for 12 
wks. Exercise consisted of walking/running on a motor-driven treadmill. During each exercise 
session participants performed a 10-min warm-up at ~70% HRmax, followed by four 4-min 
intervals at 88-92% HRmax interspersed by 3-min active recovery periods at ~70% HRmax; 
intervals were followed by a 4-min cool down at ~60% HRmax, amounting to a total exercise time 
of 42 min. HR was monitored throughout each training session, and intensity (speed or incline) 
was increased when HR failed to reach at least 88% HRmax during the high-intensity interval. 
The fasting blood draw and SAT biopsies were repeated 2d following the final exercise session 
to assess the impact of the exercise intervention and to avoid the acute effects of the last exercise 
bout on experiments. VO2peak and anthropometric tests were repeated within 1-2d of the blood 
draw and adipose biopsies.   
 
Primary Preadipocyte Isolation 
Following tissue biopsy, a small sample of subcutaneous adipose tissue was collected and 
immediately minced in Dulbecco's modified Eagle's medium (DMEM):F12 (1:1; Hyclone, 
Thermo Scientific, Logan, UT) containing 10mM glucose, 1mM pyruvate, 33μM Biotin, 17μM 
D-Pantothenate (all from Sigma Aldrich St. Louis, MO). Thereafter this medium will be referred 
to as the base medium. Upon arrival in the laboratory, the tissue was transferred to a tube 
containing the base medium completed with 1% fatty acid (FA)-free bovine serum albumin (BSA; 
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Gemini Bio-Products) and 1 mg/mL of type 1 collagenase (Worthington, Lakewood, NJ). After 
being further minced the tissue was digested for 60-75 min at 37˚C and agitated at 120 rpm. The 
larger debris were trapped via filtration through a 420 µm filter. This filtrate was centrifuged at 
300g for 10 min, the mature fat cells aspirated, and the pellet suspended in 10mL of an erythrocyte 
lysis buffer composed of 154mM NH4Cl, 10mM KHCO3 and 0.1mM EDTA, which eliminated 
most erythrocytes within 3 to 6 min. This incubation was stopped by adding 40mL of base cell 
culture medium, filtered through a 100μm filter and centrifuged at 300g for 10 min. The resulting 
pellet was suspended in 2mL of base cell culture medium containing 10% fetal bovine serum, 1μM 
epidermal growth factor, 1μM basic fibroblast growth factor, 100nM insulin, and 10nM 
hydrocortisone (growth factors and serum were from Gemini Bio-Products, West Sacramento, CA; 
insulin was from Sigma-Aldrich, St-Louis, MO). This was considered passage zero (0) and cells 
were cultured for four to eight passages before their use.  
Most experiments were performed at passage 3 to 6. None were done pass passage 8, as 
preliminary experiments performed on successive passages established that passage 8 is when 
markers of senescence are significantly upregulated. Between 1 to 3 hr prior to the experiments, 
the medium was replaced by DMEM containing 5% of calf serum, 25mM Hepes, 10mM glucose, 
reduced level of pyruvate (0.5mM), and 600μM FA-free BSA. We will thereafter refer to this as 
the experimental medium.  
 
Preparation of Fatty Acids 
All 50 mM FA stock solutions were prepared in 100mM NaOH and stored at −20°C. On 
the day of experiments, these stocks were used to prepare various 2X working solutions in the 
appropriate medium (DMEM containing 5% of calf serum, 10mM glucose, 25mM Hepes, 
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0.5mM pyruvate, and 600µM FA-free BSA). The solutions were mixed on an orbital shaker for 
45 min at 37°C. The FA proportion of these mixes was oleic acid (40%), palmitic acid (25%), 
linoleic acid (20%) and stearic acid (15%). The final FA to BSA ratio was 1.67:1. Based on the 
binding characteristics of the various fatty acids with BSA, the total free FA concentrations of 
our mixture was ~11nM with no individual fatty acid reaching concentrations above 5nM. 
 
Cell Death Determination 
Cells were maintained in the experimental medium until 30 min prior to the addition of 
FAs. At the end of the 24 hr incubation period, cells were collected with enzyme-free cell 
dissociation solution (Millipore Sigma) and incubated for 15 min at room temperature in 
Dulbecco’s phosphate-buffered saline (DPBS) containing calcein AM and ethidium homodimer 
1 at a final concentration of 0.1μM [134]. The number of live and dead cells was evaluated by 
measuring calcein AM and ethidium homodimer-1 fluorescence (Thermo Fisher Scientific, 
Pittsburgh, PA) by flow cytometry (BD Accuri Cytometers, Ann Arbor, MI, USA). Calcein AM 
is a live cell dye that is non-fluorescent and accumulates in intact healthy cells, where it acquires 
a strong green fluorescence upon cleavage by intracellular esterases [134]. Because intracellular 
esterase activity is lost as cells die, little gain in fluorescence occurs in dying or dead cells. To 
detect calcein AM we used at an excitation wavelength of 488 and a 530 ± 30nm emission filter. 
For ethidium homodimer 1 we used an excitation wavelength of 488 and a 675 ± 25nm emission 
filter. Ethidium homodimer-1 is a dye that enters damaged plasma membranes and interacts with 
nucleic acids [134]. As this interaction increases, an increase in fluorescence indicates dying or 
dead cells. In each experiment 100 % cell death was established by treating the cells with 100 % 
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methanol and FA-induced cell death was obtained by subtracting the values obtained with BSA 
alone. Each of the measurement was performed in triplicate. 
 
Measurement of Mitochondrial inner membrane Permeabilization 
Cells were treated as described above. At the end of the 24 hr incubation period, the cells 
were lifted from the dish with the enzyme-free cell dissociation solution described above and 
incubated at 37°C with 0.1μM calcein AM in DPBS for 30 min, followed by 200μM CoCl2 for 15 
min. Mitochondrial inner membrane (MIM) permeabilization was evaluated by measuring cobalt-
quenched calcein fluorescence by flow cytometry [135]. This is because calcein AM has access to 
most cellular compartments including the mitochondria.  However, cobalt (CoCl2) which quenches 
calcein fluorescence does not freely enter mitochondria unless rendered permeable due to 
permeability transition [135]. Calcein AM fluorescence was measured at an excitation wavelength 
of 488nm and emission through a 535 ± 30nm filter. The percent of cells experiencing quenching 
of calcein fluorescence was calculated by subtracting the histogram plots in the presence of calcein 
AM from the one obtained in its absence. Each of the measurement was performed in triplicate. 
 
RESULTS 
Pre-Exercise Fatty Acid Sensitivity did not differ between depots; GSQ FAS correlated 
with metabolic health markers 
In our previous study analyzing FAS in primary subcutaneous preadipocytes from an 
older population of patients undergoing CABG surgery found for individuals to vary in their 
susceptibility to FA-induced cell death and PTP [151]. We wanted to determine if this variability 
in individual FAS was also present in a younger population of healthy individuals. Primary 
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preadipocytes isolated from these young subjects also varied in their FAS (Fig. 1A-B). There 
were no differences between gluteal depots (GSQ) and abdominal depots (ASQ), thus GSQ 
results was used for the remainder of the study.  
One goal of this study was to assess the relationship between FAS and cardiovascular risk 
factors, including elevated cholesterol, LDL-c, TG, and diminished HDL-c levels. Our leading 
hypothesis was that FAS is a measure of adipocyte health, as the more sensitive the precursor 
cells are to physiologic levels of FA, the less healthy the adipose tissue is as a whole.  Pre-
exercise levels of cholesterol, TG, and LDL-c did not show any association with FAS; however, 
these was a significant negative correlation with HDL-c (Fig.1C-F). This is not unexpected as 
lower HDL-c levels are considered to be disadvantageous. 
 
12-week exercise training improved FAS and lowered cardiovascular risk factors 
After the 12-week exercise training regimen, adipose biopsies were again collected in 
abdominal and gluteal depots, of which primary preadipocytes were isolated. During the course 
of the study, there were 7 subjects that did not complete the full 12 weeks of training (Table 2). 
FAS was decreased in all but 2 of the gluteal samples (only 1 of the abdominal samples didn’t 
reduce FAS after training) (Fig.2). Exercise training is a recommended first line approach for 
lowering cardiovascular risk factors prior to pharmacologic interventions. After 12 weeks of 
exercise training, subject’s blood was again collected, and metabolic markers were measured 
(Table 2). Exercise training decreased cardiovascular risk factors cholesterol, and LDL-c, 
however had no significant effect on TG and HDL-c levels (Fig.3A-D). 
We next tested whether the preadipocytes with the highest FAS post-exercise had any 
relationship with the changes in metabolic markers with exercise. We hypothesized that the 
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higher the FAS post-exercise, the less metabolic improvement exercise conferred on the subjects. 
However, it appears that higher post-exercise FAS actually associated with more significant 
metabolic improvements (Fig.4A-D). The greater the subjects improved/lowered their 
cholesterol, TG, and LDL-c, the higher their post-exercise FAS (Fig.4A-D). This inverse 
relationship of what we expected may be due to the fact that subjects with higher post-exercise 
FAS, also exhibited higher levels of these metabolic markers pre-exercise. It stands to reason that 
the higher the levels of these metabolic markers pre-exercise, the more there is to improve with 
exercise. So, we looked at whether these pre-exercise markers held any relationship with post-
exercise FAS. Indeed, higher levels of these markers were associated with higher post-exercise 
FAS (Fig.4E-H). Interestingly, of the subjects who lowered their cholesterol and TG with 
exercise (positive responders), they also had greater improvements in their FAS as well 
(Supplemental Figure). 
 
Comparing pre-exercise FAS measurements as a predicative tool for the effectiveness of 
exercise training on lowering cardiovascular risk factors 
One aim of the study was to determine if pre-exercise FAS testing could be used as a 
predictive tool for metabolic improvements with exercise. Though there weren’t any significant 
correlations for this case, there were negative trends for changes in cholesterol, TG and HDL-c 
levels (Fig.5A-D). The higher the subjects pre-exercise FAS, the greater the improvements (or 
lowering) of cholesterol and TGs with exercise. Conversely, a decrease in HDL-c concentrations 




One established tool for evaluating cardiovascular and metabolic health is fitness testing, 
or VO2 max testing. Many studies results have suggested for fitness testing to display a positive 
relationship with cardiovascular health and increasing the level of fitness matches with 
improvements in health. Our study corroborated this relationship between improvements in 
fitness with improvements in cardiovascular health (Supplemental Figure). However, in 
comparison to pre-exercise FAS measurements, fitness testing was not a predicative tool for the 
efficacy of exercise in lowering these cardiovascular health markers (Fig 5.E-H). Interestingly, 
fitness testing could be a valid tool in predicting the efficacy of improving insulin sensitivity 
with exercise, as subject glucose and insulin levels, as well as HOMA score, displayed negative 
trends with pre-exercise fitness levels (Fig.4I-K).  
 
DISCUSSION 
In this present study we evaluated whether primary subcutaneous preadipocytes from 
younger individuals differed in their susceptibility to lipotoxicity from a physiologically relevant 
FA cocktail mix. Indeed, we did corroborate previous findings of FAS differences in older 
populations [151]; younger individuals also varied in their FAS. Furthermore, exercise improved 
this FAS, along with decreasing some of the cardiovascular risk factors. We aimed to further 
elucidate the relationship between FAS and these cardiovascular risk factors through 
correlational analyses, in which we found multiple associations between the two variables before 
and after exercise. This study provided evidence of a relationship between our measure of FAS 
and cardiovascular risk factors. 
After 12-weeks of exercise training, FAS in gluteal and abdominal depots was lowered in 
92% (22/24), and 95% (19/20) subjects. Though molecular changes with exercise in this study 
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have not been elucidated, further studies to determine how this FAS is affected by exercise are in 
store. Some possible explanations could be in part due to exercise-induced changes at the 
mitochondrial level. Exercise has been suggested to decrease mitochondrial susceptibility to 
undergo PTP [113] [115], though there aren’t any studies presently looking at this effect in 
preadipocytes. We have previously found for PTP to be a vital part of the mechanism of FA 
toxicity [27] [151], so it stands to reason that exercise-induced changes in either the molecular 
composition of the PTP, or causative agents (mtROS, calcium handling, etc.) could account for 
the improvements in FAS. Furthermore, others have found for exercise training to increase 
protein expression of Bcl-xL [157] which we have found to be a critical component of the F1F0 
ATP Synthase and PTP [151]. 
One of the main goals of this study was to establish the relationship of an individual’s 
FAS and their metabolic health. Through correlational analyses, we did find for FAS to associate 
with these markers of cardiovascular health. Along with pre-exercise FAS correlations with 
HDL-c (Fig.1F), post-exercise FAS also associated with post-exercise cholesterol, TG, and LDL-
c (Supplemental figure). Additionally, post-exercise FAS negatively correlated with changes in 
these metabolic markers (Fig.4). This was not an expected result, however may be simply 
explained by the fact that these subjects had higher levels of these markers to begin with. Indeed, 
the higher the levels of these markers prior to exercise, the higher the post-exercise FAS. It 
stands to reason then that this relationship would explain why higher post-exercise FAS would 
correlate with greater changes in these markers: there was more to lose.  
A correlation between the changes in FAS and changes in these markers with exercise 
would be a more beneficial finding in support of our proposed FAS-metabolic health 
relationship. We did not find any significance correlations between the two, however LDL and 
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HDL levels held strong trends with changes in FAS (Supplemental Figure). Furthermore, of the 
subjects who responded positively to exercise by lowering cholesterol and TG, they also trended 
to lower their FAS as well (Supplemental). This study utilized a relatively small number of 
subjects for analysis (pre-exercise n=35, post-exercise n=28) so additional subjects could give 
the statistical power to see more significant relationships. 
In terms of metabolic health and the relationship of these metabolic markers, adipose 
tissue and the liver would appear to be a linking factor. Speculatively, the regulation of 
cholesterol, TG, and fatty acid metabolism by the liver and adipose tissue could be a source of 
this FAS and cardiovascular risk factor relationship. Dysfunctional adipose tissue, as indicated 
by our FAS measurements, could have cause increased serum FFA levels, and an adverse lipid 
profile [158]. Furthermore, this increase in serum FFA, which has been found to have 
detrimental effects in multiple tissues, can exacerbate this adverse lipid problem in the liver 
[159]. Some effect of exercise training could act on both the liver, being decreased cholesterol 
synthesis, increased LDL-c uptake, and also the adipose tissue: increased cholesterol, TG, and 
FFA storage. Further work would need to be performed to evaluate these changes with exercise. 
Lastly, we aimed to determine if pre-exercise FAS could be a predicative tool for the 
efficacy of exercise in lowering cardiovascular risk factors. Again, we found trends supporting 
this relationship with cholesterol, TG, and HDL-c. However, our sample size may be limiting the 
power to see statistical significance. We decided to compare these results with a commonly used 
tool in fitness testing (VO2 max). Interestingly, pre-exercise fitness testing did not show the 
relationships with these cardiovascular risk factors that the FAS testing did. This is supported by 
previous work which displayed that though weak, there were associations between blood lipids 
and body fatness, which may be related to FAS, and no associations between aerobic fitness and 
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blood lipids [110] [112]. Whereas fitness testing was not a predicative tool for cardiovascular 
improvements with exercise, it could be a valuable tool in predicting the improvements in insulin 
sensitivity with exercise. Altogether, results indicate that these two tools, FAS and fitness 
testing, both correlate with metabolic health and may be valid tools in determining metabolic 
improvements with exercise. 
The magnitude of the effect of exercise is influenced by characteristics of the study 
design; type of exercise (chronic vs acute, endurance vs. HIIT); changes in body weight; control 
of diet, other physical activity, etc. In this study, we utilized a form of HIIT over 12 weeks, with 
an emphasis on limiting the weight loss variable. 12 weeks exercise decreased subject cholesterol 
and LDL-c levels. The effect of exercise on cardiovascular risk factors, which was evident in this 
study, can be large in some individuals, and lesser in others. Compared to current pharmacologic 
treatments for cardiovascular risk factors, the effect of exercise on these factors is not as 
significant [160], although exercise interventions have many positive components compared to 
pharmacological therapies including the lack of side effects. Additionally, the effects of exercise 
and its possible relation to FAS can be increased by other lifestyle changes such as changes in 

























































































































































































































































































































Figure 1. Pre-exercise FA sensitivity (FAS) of primary preadipocytes isolated from 
abdominal and gluteal subcutaneous adipose depots. Pre-exercise FAS negatively correlates 
with HDL-c levels. Preadipocytes were treating for 24 hours with 1000µM and (A) FA-induced 
cell death, and (B) Mitochondrial inner membrane (MIM) permeabilization was measured after 
24 hours in both preadipocytes from gluteal (GSQ, n=35) subcutaneous and abdominal (ASQ, 
n=30) subcutaneous depots. (C-F) Regression analysis was performed using the GSQ MIM 
permeabilization results with pre-exercise levels of serum markers; total cholesterol, 




































































































































































































































Figure 2. Fatty acid sensitivity is decreased following 12-week exercise training. After 12-
week exercising training, primary preadipocytes were isolated from the same subjects in GSQ 
and ASQ depots, treated with 1000µM FA cocktail for 24 hours and measured (A) the change in 
FA-induced preadipocyte cell death (pre-exercise FA-induced cell death – post-exercise cell 
death) in GSQ primary preadipocytes (n=24), (B) ASQ primary preadipocytes (n=20), (C) the 
change in FA-induced PTP (pre-exercise FA-induced PTP– post-exercise PTP) in GSQ primary 







































































































































Figure 3. 12-week exercise training decreased cardiovascular risk factors. Serum markers of 
(A-D) cholesterol, TG, LDL-c, and HDL-c were collected and analyzed pre vs. post exercise 























































































































































































































































































































Figure 4. Post-exercise FAS correlates with changes in serum markers of cholesterol and 
LDL-c with exercise. Preadipocytes were isolated after exercise from patient subcutaneous 
adipose tissue, were treated with 1000µM FA for 24 hours and MIM permeabilization was 
measured. (A-D) Post-exercise FAS correlations with the change in serum levels cholesterol, TG, 
LDL-c, and HDL-c (post-exercise – pre-exercise) (n=23). Pre-exercise serum levels of 
cholesterol, TG, and LDL-c correlate with post-exercise FAS (E-H) Post-exercise FAS 
correlations with pre-exercise serum levels of cholesterol, TG< LDL-c, and HDL-c (n=25). All 



































































































































































































































































































































































































































































































Figure 5. Pre-exercise FAS relationship with changes in metabolic markers with exercise. 
(A-D) Pre-exercise FAS relationship with the change in serum levels cholesterol, TG, LDL-c, 
and HDL-c (post-exercise – pre-exercise) (n=23). (E-H) Pre-exercise VO2 max (mL/kg) 
relationship with the change in serum levels cholesterol, TG, LDL-c, and HDL-c (post-exercise – 
pre-exercise) (n=30). (I-K) Pre-exercise VO2 max correlations with the change in subject glucose 
levels, insulin levels, and HOMA score (post-exercise – pre-exercise) (n=30). All results were 


















































































































































































Supplemental Figure 1.  Relationship between change in FAS and change in metabolic 
markers after exercise.  Post-exercise MIM permeabilization minus pre-exercise MIM 
permeabilization was calculated and analyzed vs the change in serum markers of (A-D) 
cholesterol, TG, LDL-c, and HDL-c (post-exercise levels minus pre-exercise levels). All results 










































































































































Supplemental Figure 2. Relationship of Positive/Negative Responders to Exercise vs. 
Changes in FAS with exercise. MIM permeabilization changes post-exercise – pre-exercise was 
calculated in individuals who (A) lowered cholesterol (positive (+ chol) responder, or increased 
cholesterol post-exercise (negative (- chol) responder) n=7 in each group, and (B) who lowered 





 The prevalence of obesity and related diseases of the metabolic syndrome is increasing 
exponentially, creating a public health and clinical need to improve understanding of the onset of 
obesity, and progression to metabolic diseases. It is known that FA levels rise during times of 
chronic positive energy imbalance and obesity, however how these elevated FA levels may cause 
detriment is still under investigation. Collectively, this dissertation sought to elucidate this gap in 
knowledge. The overall objective of this dissertation was to further determine the mechanism of 
FA-induced mitochondrial dysfunction and lipotoxicity in human primary preadipocytes, and 
if/how individuals differ in susceptibility to this FA toxicity. 
 In the first study, subcutaneous adipose tissue biopsied from human patients undergoing 
CABG surgery was used to investigate how primary preadipocytes from different individuals 
respond to prolonged FA exposure, and also to further FA-induced mitochondrial dysfunction 
knowledge by focusing on the PTP. The findings of this study support that preadipocytes from 
different individuals indeed do respond differently to FA exposure, which is hypothesized to play 
a role in metabolic health determination (MHO vs. MUO). Preadipocytes that were more 
sensitive to FA (FAS) were isolated from individuals that trended to be more obese compared to 
FAR counterparts, however there wasn’t a significant increase in BMI (p=.08) or A1C. However, 
the goal of this study was to study the mechanistic differences of FA sensitivity, not the clinical 
correlations. These findings do call for future studies examining aspects of adipocyte turnover 
and its role in FA sensitivity, and any clinical correlations. The first step to address this, on top 
of increasing the number of patients in the study, is to measure differentiation ability of the 
preadipocytes between these FAS and FAR subjects. 
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 Furthermore, we provide evidence of a snapshot of the components of the PTP, as MIM 
permeabilization was CypD-dependent, and Bcl-xL sensitive. Though a few studies have studied 
Bcl-xL and its relationship to the F1F0 ATP synthase in neurons, we are the first to confirm that 
Bcl-xL is bound to the F1F0 ATP synthase in preadipocytes, and in some part modulates PTP 
activity, expanding on its prior known anti-apoptotic roles. 
 Together the first study furthered data mechanistically on FA-induced mitochondrial 
dysfunction. Prior work in our lab started to elucidate this mechanism in an immortalized 
preadipocyte cell line [27], in which we confirmed in primary human preadipocytes. Prolonged 
FA exposure did increase mitochondrial ROS and preventing this oxidative stress through 
mitochondrial-specific antioxidants MitoQ and MitoTempo resulted in attenuated FA 
cytotoxicity. What is striking about these findings is the degree to which PTP and cell death was 
prevented, nearly 100%, which was the greatest mito/cytoprotective effect observed out of all 
our interventions, aside from CsA. Interestingly, MitoQ and MitoTempo each increased ATP 
regeneration at levels greater than baseline. Other studies have suggested for MitoQ to cause an 
uncoupling effect on respiration, which lowers ATP synthesis in comparison [161]. In this 
dissertation however, we did not measure the effect of these antioxidants on mitochondrial 
respiration. Further work examining this observation might add to the benefits of these 
antioxidants, and the push for the use of these supplements in self-treatment. 
Modulating FA/acetyl-CoA shuttling in/out of the mitochondria appears to play a 
significant role in FA-induced mitochondrial dysfunction. FA caused mitochondrial 
hyperacetylation, and acetylation of the F1F0 ATP synthase. Previous work has shown for SIRT3-
mediated deacetylation of CypD to induce dissociation of CypD binding within the mitochondria 
however we did not measure specific CypD acetylation [130] [162]. Additionally, Bcl-xL has 
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been shown to modulate acetyl-CoA levels further preventing cell death, possibly through its 
metabolic effects [163]. Therefore, assessing the interplay between CypD-Bcl-xL and acetylation-
specific effects in the future will be of value to further elucidate the mechanism of PTP 
induction. 
FAR preadipocytes displayed greater SIRT3 mRNA, which may account for reduced 
mitochondrial acetylation, and possibly reduced PTP and cell death. Measuring SIRT3 activity, 
as well as NAD+ levels in these groups would provide valuable insight into SIRT3’s role in 
protecting against conditions featuring elevated FA. 
L-carnitine, a substrate for CPT1-induced FA/acetyl-CoA transport in/out of the 
mitochondria, alleviated mitochondrial hyperacetylation, and resulted in PTP prevention, as well 
as preadipocyte cell death. Furthermore, trapping acetyl-CoA inside the mitochondria via 
Mildronate further exacerbated mitochondrial hyperacetylation and FA-induced mitochondrial 
dysfunction. Together the first study provides some evidence for the further exploration of 
therapeutic use of L-carnitine, targeting CRAT, and/or mitochondrial-specific antioxidants, in 
alleviating conditions resulting from elevated FAs, PTP, and/or mitochondrial oxidative stress. 
Whether L-carnitine’s protective effects were due to increased shuttling into the mitochondria for 
energy use or shuttling excess acetyl-CoA out of the mitochondria to reduce mitochondrial 
acetylation, is unclear at this time. 
 One drawback of the first study was that in theory, all the participants can be considered 
to be ultimately metabolically unhealthy as they were undergoing open heart surgery, 
discrediting any relationship between FA-sensitivity and metabolic health. So we next furthered 
our findings on individual differences in FA-sensitivity in a younger, healthier population. 
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 In the second study, we aimed to confirm our previous findings in the older patients, with 
younger patients undergoing 12-week exercise training. We also aimed to determine if exercise 
affects fatty acid sensitivity, and if there’s a correlation with the metabolic health of these 
participants, pre and post-exercise. Indeed, we did confirm our earlier findings for preadipocytes 
isolated from 35 different individuals to vary in their sensitivity to FA-induced cell death, though 
there were not any differences among abdominal (ASQ) and gluteal (GSQ) subcutaneous depots. 
FA-sensitivity negatively correlated with pre-exercise subject HDL-c levels, however didn’t 
show any significant relationships with cholesterol, LDLc, or TG prior to exercise. 
 After 12 weeks of exercise training, 92% - 95% of subjects displayed improved FA-
sensitivity in their isolated preadipocytes. This effect could be due to a number of reasons 
including exercise-induced increases in FA-utilization, or greater sirtuin deacetylase activity in 
the mitochondria [164] [165]. Exercise training also significantly lowered subject cholesterol and 
LDL-c levels. Unexpectedly, these improvements were correlated with higher post-exercise FA-
sensitivity. We hypothesized FA-sensitivity would be driving metabolic health, however it is 
possible that pre-exercise levels of lipids could be determining FA-sensitivity. This was seen in a 
correlation of subjects with higher pre-exercise levels of these lipid markers and higher post-
exercise FA-sensitivity. In the future this relationship could be further investigated substituting 
cholesterol-lowering agents in place of exercise to determine their effect on FA-sensitivity.  
A goal of the study was to determine if pre-exercise FA-sensitivity could be used as a 
predicative tool in determining the efficacy of exercise training on metabolic health. There were 
trends for pre-exercise FA-sensitivity to correlate with greater improvements in cholesterol and 
TG, however we did not reach the power to see significance. All of the subjects in the exercise 
study were considered metabolically healthy, so in the future it would be interesting to determine 
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the effects of exercise training, and relationship of FA-sensitivity in subjects with some 
metabolic disturbance (insulin resistance, hyperlipidemia, etc.). Also, it would be worthwhile to 
determine the role of Bcl-xL, CypD, and the FA-acetyl-CoA transport system serves in the 
determination of FA-sensitivity in these younger individuals. There’s plenty of evidence of age-
related decline in NAD+ and sirtuin activity, making it interesting to determine if mitochondrial 
acetylation which we observed in the first study, could be playing as much of a role in these 
younger individuals. 
 Altogether, this dissertation furthered knowledge of the mechanism of FA-induced 
mitochondrial dysfunction and lipotoxicity in human primary preadipocytes. However, it is 
important to note that whether this the observed cell death in an in-vivo atmosphere is good, or 
bad, has not been elucidated. It’s known that cell death can serve a physiologic role and can be 
beneficial for a system as a whole. Our hypothesis was that observed cell death is a negative 
consequence of elevated FA exposure. However, it stands to reason that this cell death could 
possibly be a protective feature of the adipose atmosphere; ridding adipose tissue of these 
unhealthy precursors, possible to make way for new healthy preadipocytes and concurrent 
adipogenesis. However, it is the belief of this dissertation that the chronic “killing off” of a high 
number of preadipocytes decreases the adipogenic potential of the adipose organ system, and 
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